Podcasts about american society

About this episode: In vitro fertilization, or IVF, is a game changing reproductive technology that leads to more than 2% of births in the U.S. But high costs and a lack of coverage options put it out of reach for many would-be parents. In this episode: Sean Tipton of the American Society for Reproductive Medicine discusses how new federal policies are moving the dial on IVF access and where more work needs to be done. Guests: Sean Tipton, MA, is the Chief Advocacy and Policy Officer at the American Society for Reproductive Medicine, a non-profit representing over 7,000 members focused on advancing the science and practice of reproductive medicine. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Fact Sheet: President Donald J. Trump Announces Actions to Lower Costs and Expand Access to In Vitro Fertilization (IVF) and High-Quality Fertility Care—The White House American Society for Reproductive Medicine Reacts to White House Announcement on IVF Coverage—American Society for Reproductive Medicine The Alabama Supreme Court's Ruling on Frozen Embryos—Public Health On Call (February 2024) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Get the full show notes: https://www.draimee.org/intrauterine-surgery-and-other-life-saving-interventions-with-dr-emery-and-dr-sanfilippo In this episode, I'm joined by two incredible guests: Dr. Steven Emery, a maternal fetal medicine specialist and director of the Center for Innovative Fetal Intervention at the University of Pittsburgh, and Dr. Joseph Sanfilippo, a renowned reproductive endocrinologist, past President of the American Society for Reproductive Medicine, and author of "Everyday Medical Miracles." Together, we explore the latest advances in intrauterine surgery, fetal interventions, and fertility innovations that are changing lives for families everywhere. In our conversation, we dive deep into the courage and hope that medical innovation brings to patients. Dr. Emery and Dr. Sanfilippo share real-life stories, discuss the evolution of fetal and reproductive care, and offer practical advice for anyone navigating fertility or high-risk pregnancies. We also touch on the future of medicine, from gene therapy to the impact of artificial intelligence in the embryology lab. In this episode, we cover: A remarkable case of fetal anemia and the life-saving power of intrauterine transfusions What pre-implantation genetic testing (PGT) is: and what it can and can't detect The latest interventions for fetal conditions, including twin-twin transfusion syndrome and fetal hydrocephalus How to prepare for pregnancy: lifestyle, medical, and genetic considerations The role of maternal fetal medicine specialists and when to seek their expertise New research and approaches to fibroid prevention and treatment The future of fertility and fetal medicine, including gene therapy and AI Resources: Dr. Sanfilippo's book website: Everyday Medical Miracles or order via Amazon Dr. Sanfilippo's book Expert Guide to Fertility via Amazon Dr. Emery's email: emerysp @ upmc.edu Dr. Sanfilippo's email: sanfjs @ upmc.edu American College of Obstetricians and Gynecologists: acog.org American Society for Reproductive Medicine: asrm.org Join me for a screening of the movie THAW: Parenthood on Ice. Wednesday November 5: Doors Open 6 PM / Screening starts 6:30 PM Alamo DraftHouse, Mountain View, California The screening will be followed by a panel discussion with Dr. Aimee (me!), Ivana Muncie-Vasic (Vitra Labs), Prof. Hank Greely and other fertility tech experts. Moderated by Sara Vaughn, MD. THAW examines the rapidly growing egg and embryo freezing industry, revealing its profound implications for women's reproductive health and rights. Through the stories of three American women navigating the world of fertility preservation, the film sheds light on the deeply personal, social, and ect. Get your tickets here. Subscribe to my YouTube channel for more fertility tips! Join Egg Whisperer School Checkout the podcast Subscribe to the newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.

All EAs are project managers, but are you leveraging project management frameworks and tools? Learn about the skillset and principles you need to wow executives with expert Tareka Wheeler, PMP. Recorded at EA Ignite Spring 2025 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

As our understanding of pain physiology evolves, neuromodulation continues to offer new treatment possibilities in MSK pain management. In this episode of the BackTable MSK, host Jacob Fleming discusses the evolving world of neuromodulation with Dr. Timothy Deer, a leading expert in the field. Dr. Deer shares insights from his extensive career and his innovative contributions in neuromodulation.---This podcast is supported by:Medtronic Osteocoolhttps://www.medtronic.com/en-us/healthcare-professionals/products/surgical-energy/ablation/radiofrequency-ablation/systems/osteocool-2-0-bone-tumor-ablation-system.html---SYNPOSISThe conversation covers the development of spinal cord and dorsal root ganglion (DRG) stimulation, the significance of patient selection and challenges facing neuromodulation therapies, and exciting developments in the field, including AI. Dr. Deer and Dr. Fleming also discuss the importance of advanced training and the pioneering work by the American Society of Pain and Neuroscience (ASPN) to improve procedural education through its innovative MIS Certification Program.---TIMESTAMPS00:00 - Introduction02:52 - What is Neuromodulation?06:03 - Evolution of Neuromodulation08:49 - Use of Closed Loop and AI 13:58 - DRG Stimulation Explained19:58 - Progression of Peripheral Nerve Stimulation26:26 - Handheld Navigation and Reducing Radiation Exposure 30:18 - The Umbrella of Specialties within ASPN35:15 - Obtaining MIS Certification and Fellowship Program Outlook44:07 - Future Directions of Neuromodulation48:09 - Concluding Thoughts---RESOURCESDr. Timothy Deer, MDhttps://centerforpainrelief.com/doctor-timothy-deer/ American Society of Pain and Neuroscience (ASPN)https://aspnpain.com/

Most people don't realize that what happens in the mouth can ripple through the whole body. The balance of the oral microbiome—the community of bacteria living in our mouths—can either protect us or trigger widespread inflammation that affects the heart, joints, and brain. Hidden dental infections or mercury fillings can quietly drive fatigue, autoimmune issues, or dementia—and fixing the mouth often helps the rest of the body heal, too. The good news is that with simple steps like eating whole foods (often removing gluten), cleaning the mouth well, and breathing through the nose, we can protect both our smile and our overall health. When we care for the mouth as part of the body, lasting wellness becomes possible from the inside out. In this episode, Dr. Todd LePine, Dr. Elizabeth Boham, James Nestor, and I talk about how a healthy mouth microbiome is a key to whole-body wellness. Dr. Todd LePine graduated from Dartmouth Medical School and is Board Certified in Internal Medicine, specializing in Integrative Functional Medicine. He is an Institute for Functional Medicine Certified Practitioner. Prior to joining The UltraWellness Center, he worked as a physician at Canyon Ranch in Lenox, MA, for 10 years. Dr. LePine's focus at The UltraWellness Center is to help his patients achieve optimal health and vitality by restoring the natural balance to both the mind and the body. His areas of interest include optimal aging, bio-detoxification, functional gastrointestinal health, systemic inflammation, autoimmune disorders, and the neurobiology of mood and cognitive disorders. Dr. Elizabeth Boham is Board Certified in Family Medicine from Albany Medical School, and she is an Institute for Functional Medicine Certified Practitioner and the Medical Director of The UltraWellness Center. Dr. Boham lectures on a variety of topics, including Women's Health and Breast Cancer Prevention, insulin resistance, heart health, weight control and allergies. She is on the faculty for the Institute for Functional Medicine. James Nestor is an author and journalist who has written for Scientific American, Outside, The New York Times, and more. His book, Breath: The New Science of a Lost Art, was an instant New York Times and London Sunday Times bestseller. Breath explores how the human species has lost the ability to breathe properly—and how to get it back. Breath spent 18 weeks on the New York Times bestseller list in the first year of release, and will be translated into more than 30 languages. Breath was awarded the Best General Nonfiction Book of 2020 by the American Society of Journalists and Authors, and was nominated for Best Science Book of 2021 by the Royal Society. Nestor has spoken at Stanford Medical School, Yale School of Medicine, Harvard Medical School, The United Nations, Global Classroom, and appeared on more than 60 radio and television shows, including Fresh Air with Terry Gross, the Joe Rogan Show, and more. He lives and breathes in San Francisco. This episode is brought to you by BIOptimizers. Head to bioptimizers.com/hyman and use code HYMAN to save 15%. Full-length episodes can be found here:The Functional Medicine Approach To Oral Health Getting Rid of Cold Sores and Canker Sores The Power Of Breath As Medicine

Seen TikTok videos about taking "just a little bit" of Ozempic or counting pen clicks instead of using the prescribed dose? That's microdosing, and it's showing up everywhere—from social media to patient discussions. In this episode, I will cut through the hype to explain what microdosing GLP-1 medications really means, why people are trying it (spoiler: cost and side effects), and what the research actually says. I will discuss the concept of "super responders" who seem to do well on lower doses, the lack of scientific backing for DIY microdosing, and the real risks of using compounded or diluted versions of these medications. Tune in to learn why working with your healthcare provider is essential for safe, effective dosing—and discover legitimate ways to manage side effects and costs without compromising your results.   Episode Highlights: What microdosing GLP-1s actually means The difference between super responders and unsafe microdosing Why professional organizations don't endorse microdosing Hidden risks of compounded and diluted medications Safe alternatives for managing side effects and medication costs   Connect with Dr. Alicia Shelly: Website | drshellymd.com Facebook | www.facebook.com/drshellymd Instagram | @drshellymd Linked In | www.linkedin.com/in/drshellymd Twitter | @drshellymd About Dr. Alicia Shelly Dr. Alicia Shelly was raised in Atlanta, GA. She received her Doctorate of Medicine from Case Western Reserve University School of Medicine in Cleveland, OH.  Dr. Shelly has been practicing Primary Care and Obesity medicine since 2014.  In 2017, she became a Diplomat of the American Board of Obesity Medicine. She is the lead physician at the Wellstar Medical Center Douglasville. She started a weekly podcast & Youtube channel entitled Back on Track: Achieving Healthy Weight loss,  where she discusses how to get on track and stay on track with your weight loss journey. She has spoken for numerous local and national organizations, including the Obesity Medicine Association, and the Georgia Chapter of the American Society of Metabolic and Bariatric Surgeons. She has been featured on CNN, Fox 5 News, Bruce St. James Radio show, Upscale magazine, and Shape.com. She was named an honoree of the 2021 Atlanta Business Chronicle's 40 under 40 award. She also is a collaborating author for the, “Made for More: Physician Entrepreneurs who Live Life and Practice Medicine on their own terms''.   Resources: FREE! Discover the 5 Reasons Your Weight-Loss Journey Has Gotten Derailed (And How To Get Back On Track!)

We are thrilled that this podcast is airing right after the 2025 American Society for Bioethics and Humanities meeting. It is based on a 2024 ASBH workshop “Remaking Bioethics Together.” Our guests are Stephen Molldrem, PhD, assistant professor and the research program director in Bioethics and Health Humanities at the University of Texas Medical Branch School of Public and Population Health, Krishna Chokshi, MD, associate professor of medicine in the division of hospital medicine at the Mount Sinai Hospital in NYC, Jonathan Shaffer, PhD, assistant professor in the department of sociology at the University of Vermont and Zackary Berger, MD, PhD, associate professor at the Johns Hopkins Bloomberg School of Public Health and in the division of general internal medicine at the Johns Hopkins School of Medicine. Our guests discuss what led them to organize that workshop, beginning with an appreciation of how the principlist, individualist approach of bioethics falls short in addressing systemic challenges to equitable healthcare. Dr. Shaffer shared how his interest in remaking bioethics stems from observations of the focus on “fringe science” in ASBH meetings and the relative absence of more politically oriented moral theorizing. He discusses how sociological frames can help think about the production of shared norms and moral values. Drs. Berger and Chokshi discuss clinical systems ethics failures and what it would mean for Bioethics to think of Capitalism as an object of moral inquiry and to consider organizational ethics in relationships between Academic Medical Centers and communities. We discuss how the “imagined neutrality” of the field of Bioethics has evaporated in the recent overlapping crises of academic medicine. Dr. Molldrem discussed political organizing and the need to take power and its functioning seriously. At the 2025 ASBH meeting last week, this group took the next steps to begin organizing the field by recognizing threats and opportunities and considering resources at our disposal to effect change. Next steps include fostering scholarship around these ideas, considering methods of institutional change within bioethics institutions and collaborating within and across disciplines to foster change. Please reach out to us or our guests if you are inspired to join this crucial work.

In this "Giants in Plastic Surgery" episode of the PRS Global Open Deep Cuts Podcast, we sit down with Dr. Steven Williams for an inspiring and candid conversation that goes beyond the surface of success. We dive into the moments that shaped his journey — from battling imposter syndrome to finding his calling in plastic surgery, and from his experiences at Yale University to building a technology company while still in residency. Dr. Williams reflects on the lessons learned along the way, the influences that guided him, what it means to lead as president of the American Society of Plastic Surgeons (ASPS), and his vision for breaking barriers and expanding access to care in the communities he serves. Dr. Williams is a board-certified plastic surgeon, founder of Tri Valley Plastic Surgery in Dublin, California, and the 2023-2024 president of the ASPS, the world's largest organization of board-certified plastic surgeons. He earned his undergraduate degree from Dartmouth College and went on to complete medical school and residency at Yale University, where he made history as the first African American to graduate from Yale's plastic surgery program. His career is marked by a dedication to excellence, education, and representation in medicine. As the first African American president of ASPS, Dr. Williams has focused his leadership on technology, innovation, and diversity — ensuring that plastic surgery continues to advance while remaining inclusive and accessible. His story is one of perseverance and purpose, illustrating how leadership, vision, and compassion can shape not only a career but an entire specialty. Your host, Dr. Vimal Gokani, is a senior Specialty Registrar in plastic surgery in London, England. Your producer & editor, Charlene Kok, is a Year 4 Medical Student in Imperial College London, England, with a keen interest in Plastic Surgery.  #PRSGlobalOpen #DeepCutsPodcast #PlasticSurgery #GiantsPlasticSurgery

This episode features Dr. Joao Xavier PhD, a systems biologist from Memorial Sloan Kettering Cancer Center, speaking about the application of ecological principles and tools to individuals being treated for cancer. His lab combines multi-omics profiling with ecological models to generate insights on how microbes interact with each other, for application to clinical risk prediction and microbiota-focused interventions. He has studied individuals receiving bone marrow transplantation, who take antibiotics to prepare for treatment; the antibiotics cause significant gut microbiota shifts and the risk of bloodstream infections increases, so his lab is looking at whether the gut microbiota could mitigate this risk. Currently microbiome monitoring is not being used clinically in patients receiving cancer treatments, but a path exists for gaining the evidence needed to make this feasible and useful. Potentially, microbiome monitoring could allow physicians to move from reactive treatment with antibiotics to proactive intervention that prevents serious infections. Or the clinician could simulate potential treatment scenarios and figure out which one is the most beneficial. Probiotics could be administered to shape the microbiome – but rather than adding microorganisms that may simply be missing, these probiotics would be developed by thinking about the microbiome outcome and how to pressure the ecosystem in a certain direction. Episode abbreviations and links: Review in Nature Reviews Clinical Oncology, arguing for the relevance of microbiota management guided by ecological principles in cancer care: making the case for Ecological management of the microbiota in patients with cancer Mouse study investigating what may drive an increase in oral bacteria within the fecal microbiota and how it may link to patient outcomes: Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes About Dr. Joao Xavier PhD: Joao B. Xavier, PhD, is a faculty member in the Program for Computational and Systems Biology at Memorial Sloan Kettering Cancer Center in New York. His lab combines experiments, computational modeling, and clinical data to study how the human microbiota influences cancer treatment outcomes. Dr. Xavier's work has uncovered links between gut bacteria, immune recovery, and infection risk in patients undergoing intensive therapies such as allogeneic hematopoietic stem cell transplantation. He recently authored a Nature Reviews Clinical Oncology article (2025) proposing “ecological management” of the microbiota in oncology. This approach applies principles of ecosystem management to preserve beneficial microbes, minimize treatment-related damage, and guide precision interventions. He was awarded the 2026 ASM Microbiome Data Prize by the American Society for Microbiology in recognition of these contributions. His group collaborates broadly across clinical and basic sciences to develop microbiota-informed strategies that could improve responses to chemotherapy, immunotherapy, and infection control.

Archie is still promoting his song entitled, “Leave Us Face It, We're In Love.” Now he has made a symphonic arrangement and tries to get Duffy's guest, composer, commentator, music critic, and author, Deems Taylor, to get him into ASCAP, the American Society of Composers, Authors and Publishers, of which Deems is the president.Originally aired on January 25, 1944. This is episode 114 of Duffy's Tavern.Please email questions and comments to host@classiccomedyotr.com.Like us on Facebook at facebook.com/classiccomedyotr. Please share this podcast with your friends and family.You can also subscribe to our podcast on Spreaker.com, Spotify, iTunes, Stitcher, TuneIn, iHeartRadio, and Google podcasts.This show is supported by Spreaker Prime.

From the deteriorating Gowanus Expressway in Brooklyn, New York, to the aging dams that supply about 70 percent of California's water, America's public infrastructure is badly in need of fixing. The nation is estimated to have accumulated about $1 trillion in deferred infrastructure maintenance, and even more will be needed to rebuild or retrofit roads, water plants, schools, and electrical grids to withstand the punishments of increasingly extreme weather. William Glasgall, Penn IUR Fellow and Volcker Alliance Public Finance Adviser, Susan Wachter, Co-Director of Penn IUR and Wharton professor, and our expert panel discuss the state of America's infrastructure and how some states are developing strategies to better identify and fund needed investments. Panelists include: • Geoffrey Buswick, Managing Director & Sector Leader in U.S. Public Finance, S&P Global Ratings • Camila Fonseca Sarmiento, Director of Fiscal Research, Institute for Urban and Regional Infrastructure Finance • Hughey Newsome, Chief Financial Officer, Sound Transit • Leslie Richards, Professor of Practice, City and Regional Planning, Weitzman School of Design and Former CEO of SEPTA • Fatima Yousofi, Senior Officer, The Pew Charitable Trusts. NOTABLE QUOTES Notable Quotes -Fatima Yousofi: “Just like we've seen with public pension underfunding in the past, these hidden costs can quietly accumulate for years until they really start crowding out spending priorities and straining government budgets.” -Fatima Yousofi: “Pew's research shows that states have accumulated more than $105 billion in unmet road and bridge repair needs since 1999. And at the same time, the EPA estimates that we might need to spend another $1.2 trillion over the next 20 years to modernize our drinking water, wastewater, and stormwater systems.” -Camila Fonseca Sarmiento: “In recent years, there has been an increase in the funding sources that are available to address deferred maintenance. I'm not saying that there is funding that is high for deferred maintenance. Actually, when we look into the 10 case studies, the funding that is allocated for deferred maintenance only covers 4% of the total need, so that is very low.” -Geoffrey Buswick: “In 25, we're on track for nearly $600 billion in municipal bond volume, and that is an all-time high mark after last year, which was also an all-time high mark.” -Geoffrey Buswick: “So, in the industry, we've become accustomed to federal government incentivizing capital projects through regulations, grants, project matching funds, but as these tools are being curtailed or cut at the federal level, more of the costs are likely to fall to other levels of government. This could further challenge this needed upkeep in spending. And at a time when the American Society of Civil Engineers is estimating about $3.7 trillion of capital needs above current funding levels over the next 10 years, simply to get to a level of good repair?” -Leslie Richards: “you can't maintain your way out of a 50-year-old fleet. At some point, the equipment simply needs to be replaced. And that's where the financial pressure comes in.” -Leslie Richards: “I often describe it this way, using capital funds for operations is like using your roof repair fund to pay the light bill. It keeps things working today, but the storm is still coming, and you need a strong roof. And SEPTA is not alone in this. Agencies all over the country are being forced into the same trade-offs.” -Leslie Richards: “we can't keep running 21st century service on 20th century equipment with 19th century funding models. We have to build a new approach, one that values reliability, transparency, and safety of the people who ride and operate these systems every day.” -Hughey Newsome: “agencies, as best as they can, have to think through how do you find other stable sources, given that, there's always going to be volatility coming from Washington.”

This week on The best in pet talk radio, The Pet Buzz, Petrendologist Charlotte Reed is discussing October as Pet Health and Wellness month with American Veterinary Medical Association President Dr. Michael Q Bailey and as well as October as National Animal Safety and Protection Month with American Society for the Prevention of Animals, Dr. Tina Wismer.

I'm going to begin with a wonderful quote from a recent editorial in Bioethics by our guests Parker Crutchfield & Jason Wasserman. This quote illustrates the tension between the widely held view in bioethics that slow codes are unethical, and the complexity of real world hospital practice: “Decisive moral positions are easy to come by when sitting in the cheap seats of academic journals, but a troubling ambivalence is naturally characteristic of live dilemmas.” Gina Piscitello, our third guest, recently surveyed doctors, nurses and others at 2 academic medical centers about slow codes.  In a paper published in JPSM, she found that two thirds had cared for a patient where a slow code was performed.  Over half believed that a slow code is ethical if they believed the code is futile. Slow codes are happening. The accepted academic bioethics stance that slow codes are unethical is not making it through to practicing clinicians. Our 3 guests were panelists at a session of the American Society of Bioethics and the Humanities annual meeting last year, and their panel discussion was apparently the talk of the meeting. Today we talk about what constitutes a slow code, short code, show code, and “Hollywood code.” We talk about walk don't run, shallow compressions, and…injecting the epi into the mattress! We explore the arguments for and against slow codes: harm to families, harm to patients, moral distress for doctors and nurses; deceit, trust, and communication; do outcomes (e.g. family feels code was attempted) matter more than values (e.g. never lie or withhold information from family)? We talk about the classic bioethics “trolley problem” and how it might apply to slow codes (for a longer discussion see this paper by Parker Crutchfield).  We talk about the role of the law, fear of litigation, and legislative overreach (for more see this paper by Jason Wasserman). We disagree if slow codes are ever ethical.  I argue that Eric's way out of this is a slow code in disguise. One thing we can all agree about: the ethics of slow codes need a rethink. Stop! In the name of love. Before you break my heart. Think it over… -Alex Smith  

Synopsis: Host Rahul Chaturvedi sits down with Geoffrey Duyk, Chief Executive Officer of Grove Biopharma, for a wide-ranging conversation on navigating today's biotech macro headwinds and building companies that can translate breakthrough science into real patient impact. Dr. Duyk traces his journey from Harvard/Millennium/Exelixis operator to TPG investor and back to company creation, explaining how board dynamics, capital cycles, and policy shifts shape execution. They dig into why this cycle feels uniquely tough—patent cliffs, reimbursement uncertainty, NIH pressures—and who funds innovation in the meantime. Duyk outlines root causes of R&D inefficiency (misaligned capital vs. 20-year timelines, shaky preclinical predictability, costly trials, underused real-world data) and makes the case for rebuilding public trust and STEM education. Then, a deep dive on Grove Biopharma: precision polymer science that creates antibody-like, fully synthetic, cell-permeable protein mimetics to tackle historically “intractable” intracellular protein–protein interactions. Duyk shares design principles, why modular/orthogonal chemistry matters, predictable pharmacology, and lessons from fundraising and board management—plus why he's helping grow a Chicago-centered biotech ecosystem. Biography: Geoffrey M. Duyk, M.D., Ph.D. is the Chief Executive Officer of Grove Biopharma. Dr. Duyk has spent 30 years in the biotechnology industry as an entrepreneur, executive, and investor. Most recently, he was the Managing Partner at Circularis Partners, an investment firm he co-founded, focused on advancing the circular economy and promoting sustainability. Prior to that, Dr. Duyk was Managing Director and Partner at TPG Alternative & Renewable Technologies (ART)/TPG Biotechnology. Before joining TPG, Dr. Duyk served as a board member and President of R&D at Exelixis and was one of the founding scientific staff members at Millennium Pharmaceuticals, where he served as Vice President of Genomics. Earlier in his career, Dr. Duyk was an Assistant Professor in the Department of Genetics at Harvard Medical School (HMS) and an Assistant Investigator at the Howard Hughes Medical Institute (HHMI). While at HMS, he served as a co–principal investigator in the Cooperative Human Linkage Center, which was funded by the National Institutes of Health (NIH). Dr. Duyk is a trustee of Case Western Reserve University, where he serves on the executive committee. He previously served on the Board of Trustees of Wesleyan University and the Board of Directors of the Moffitt Cancer Center. He currently serves on the IR&E (Institutional Research and Evaluation) Committee at Moffitt, a key component of its External Advisory Committee (EAC). He was also a member of the Board of Directors of the American Society of Human Genetics (ASHG), and served as its treasurer. He is a member of the Life Sciences Advisory Board at Innovatus Capital Partners and the Scientific Advisory Board (SAB) for Lawrence Berkeley National Laboratory (DOE). Dr. Duyk previously served on the board of the Jackson Laboratory and on numerous NIH advisory committees. He is currently a Senior Advisor at Qiming Venture Partners (USA) and serves on the boards of Enno DC, Oobli, and Melanyze Dr. Duyk earned both his M.D. and Ph.D. from Case Western Reserve University and completed his medical and fellowship training at the University of California, San Francisco (UCSF). While at UCSF, he was a Lucille P. Markey Fellow and an HHMI postdoctoral fellow. He is a fellow of the American Association for the Advancement of Science.

Anesthesiology 2025, the annual meeting of the American Society of Anesthesiologists, Desiree Chappell speaks with her guest, David Kennedy, Emeritus Professor at the University of Pennsylvania. They discuss the complexities of value-based care models and the essential role of Anesthesia Information Management Systems (AIMS). Dr. Kennedy, with his extensive experience in both private practice and large anesthesia groups, explains the benefits and functionality of AIMS. He highlights how AIMS can optimize data access, improve patient care through real-time analytics, and enhance operational efficiency. Additionally, the conversation covers the integration of AI in these systems, its potential to transform standard care practices, and the need to address data security and clinician skill retention. The episode concludes with the importance of portable AIMS platforms for practitioners working in diverse medical environments.

Interview with Katharine Yao, MD, MS, and Lorraine Tafra, MD, authors of American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions. Hosted by Jamie Coleman, MD. Related Content: American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions

Interview with Katharine Yao, MD, MS, and Lorraine Tafra, MD, authors of American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions. Hosted by Jamie Coleman, MD. Related Content: American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions

Optimizing time management for yourself and the executives you support is an EA superpower. Note the steps and tools to conduct a strategic time audit from processes and procedures expert Julie Perrine. Recorded at EA Ignite Spring 2025 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Andy Cumpstey and Kate Leslie take us to Anesthesiology 2025, the annual meeting of the American Society of Anesthesiologists (ASA), where they spoke with Samer Narouze, Chairman of the Center for Pain Medicine at Western Reserve Hospital and Chair of the Pain Committee for the ASA. Samer introduces the newly formed Pain Medicine Coalition, which aims to improve patient access to pain care and advocate for pain specialists. The coalition, an alliance between prestigious organizations, focuses on reducing barriers to non-opioid pain treatments and legislative advocacy for better coverage. He also discusses the importance of comprehensive, evidence-based pain management and the recent launch of a Certificate of Innovation and Leadership in Pain Medicine to support newly graduated pain fellows. The discussion highlights the coalition's efforts to rebrand and advance the field of pain medicine toward a more patient-centric and multidisciplinary approach.

In this episode, we explore one of the most infamous poltergeist cases in North America: the so-called Great Amherst Mystery, which occurred in Amherst, Nova Scotia in 1878-79. Centering on 18-year-old Esther Cox, her sister's household and the investigator Walter Hubbell, we walk through the bewildering phenomena of objects flying, knocks on the wall, unexplained fires, swelling seizures, and the question: was this supernatural, psychological or a hoax?   We trace the narrative from its traumatic catalyst through the escalation of events, the public spectacle, the investigation, and the eventual fading of activity. We also dig into the skeptical evaluations, the cultural context of spiritualism in the 19th century, and what this case tells us about the human mind, belief and the boundary between the seen and unseen.  

Dr. Uri Tabori is a Staff Physician in the Division of Haematology/Oncology, Senior Scientist in the Genetics & Genome Biology program, and Principal Investigator of The Arthur and Sonia Labatt Brain Tumour Research Centre at The Hospital for Sick Children (SickKids). Uri is also a Professor in Paediatrics and Associate Professor in the Institute of Medical Sciences at the University of Toronto. Uri works as a physician treating kids with cancer, particularly brain tumors. Through his research, he is working to identify drugs and make new discoveries that may cure cancers or improve patients' lives. When he's not hard at work in the lab or clinic, Uri enjoys spending time with his family, watching American football, and exploring the wilderness of Canada. He is especially fond of canoeing and canoe camping with his family. He received his MD from the Hadassah School of Medicine of Hebrew University in Israel. Afterwards, he completed a Rotating Internship and his Residency in Pediatrics at the Sorasky Medical Center in Israel. Next, Uri accepted a Fellowship in Pediatric Hematology and Oncology at the Sheba Medical Center in Israel. He served as a Staff Physician in Pediatric Hematology and Oncology at The Sheba Medical Center for about a year before accepting a Research and Clinical Fellowship at The Hospital for Sick Children in Canada SickKids where he remains today. Over the course of his career, Uri has received numerous awards and honors, including the Early Researcher Award from the Ontario Ministry of Development and Innovation, the New Investigator Award from the Canadian Institute of Health Research, the Junior Physician Research Award from the University of Toronto Department of Pediatrics, The New Investigator Award from the Terry Fox Foundation, A Eureka! new investigator award from the International Course of Translational Medicine, A Merit Award from the American Society of Clinical Oncology Annual Meeting, and The Young Investigator Award from the Canadian Neuro-Oncology Society. In our interview, Uri shares more about his life, science, and clinical care.

Desiree Chappell and Mike Grocott at the American Society of Anesthesiologists (ASA) Annual Meeting have our traditional conversation with the incoming and outgoing Presidents of the organisation. Incoming President Dr. Patrick Giam and outgoing President Dr. Don Arnold to discuss their careers, initiatives, and the future of anesthesiology. Topics include advancements in perioperative medicine, the importance of mentorship, strategies for increasing member engagement, and the integration of new technologies like artificial intelligence. Both leaders share their visions for the ASA, emphasizing leadership development, professional growth, and improving patient care.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Helen Johnson and Dr. Katrina Mitchell the management of patients with breast cancer diagnosed during pregnancy or lactation, and guidance provided regarding surgery, radiation, and systemic therapy, as reported in the article, "Oncolactation for Patients with Breast Cancer: Executive Summary from the American Society of Breast Surgeons."

Send Bidemi a Text Message!In this episode, host Bidemi Ologunde traced the tech and cyber forces reshaping everyday life in the United States: why Washington, DC builds more affordable housing per capita than Texas and California; how OnlyFans, online betting, and sober-curious culture are rerouting tourists from Las Vegas and theme-parks; and why zero-income-tax states in the U.S. (Alaska, Wyoming, South Dakota, and New Hampshire) don't have big cities. He connects the dots with clear risks, opportunities, and pragmatic policy ideas communities can use now.Support the show

Mandy Szigethy discovered upholstery while completing her Theater Technology degree at Indiana University and decided to forsake the stage in favor of the workshop.  She has had the unique opportunity to work in both furniture manufacturing at Beachley Furniture and now custom upholstery as the owner of Rose City Upholstery in Portland.  She has received training in both modern materials and traditional methods through Upholstery Education and is now able to apply time tested techniques to all of her projects.  Her love of learning lead to her to co-ownership of Upholstery Education in 2025 where she hopes to foster the same enthusiasm in others.   Her passion for revitalizing and repurposing home furnishings has led to an in depth--if unintentional--study of older and newer furniture, and the potential of any antique store or curbside find.   Marta Powers is the owner of MartaPOW LLC, a custom workroom in Richmond, Virginia, offering upholstery and soft goods services nationally To The Trade.  Her past career as a project manager for architecture and design firms has informed her business processes and broadened her network of professionals across the hospitality and interior design sectors.  Marta's early training in tailoring, pattern drafting, clothing design, and fabrication skills led to her creation of a business serving designers, helping them to achieve their and their clients' vision.     A co-owner of Upholstery Education LLC, Marta and her partners bring educators from the UK and France to the U.S., offering courses in traditional upholstery methods, materials, and related interior furnishing trades.     Marta has served on the boards of the National Upholstery Association and the Virginia chapter of the American Society of Interior Designers (as an Industry Partner).  She is also a member of IFDA Richmond, the SeatWeavers Guild, and the NUA's Education Committee. Justin Dazey is the owner of Foxglove Artisan and Castillo's Custom Upholstery on Queen Anne Hill in Seattle, Washington. Justin has a BA in Interior Design and over 30 years of experience in the antiques, interiors, and furniture world. In 2014, Justin took up sweeping floors in the shop of a third-generation Upholstery family. He brought his design skills and furniture history knowledge to the role of Studio Manager, eventually becoming their lead upholsterer. In 2024, Justin took up the mantle as his mentor retired, becoming the owner, designer, and upholsterer of the Seattle Studio. Most recently, Justin partnered with Marta Powers and Mandy Szigethy to acquire Upholstery Education, offering the very best in traditional upholstery training available in the United States. Justin is a collector at heart. He collects history, chairs, and curiosities. He firmly believes every piece has a story to tell and loves bringing old items back to life through patient and accurate restoration. Sharing his insights and seeking education to honor the traditions of craft and furniture is one of his true passions.      Links and Resources; Upholstery Edcuation  

It was a real pleasure to welcome Kathleen Kosmoski, Director of Workforce Development at the American Society of Mechanical Engineers (ASME), to Manufacturing an American Century. Kathleen leads national efforts to strengthen the engineering talent pipeline and is helping connect community colleges, manufacturers, and engineering societies in new ways to close the skills gap.Kathleen shares how ASME is engaging the next generation of engineers through its Community College Engineering Pathways and Mechanical Engineering Technology Apprenticeship programs, both designed to make engineering education more accessible and aligned with industry needs. She discusses how these initiatives are helping students enter the engineering profession as technicians and advance through hands-on learning and employer partnerships.We also talk about the unique role of professional societies in rebuilding America's manufacturing base, ASME's collaborations with other engineering associations, and Kathleen's vision for a more connected and inclusive technical workforce. Her experience leading workforce initiatives and her passion for solving complex challenges shine through as she describes how trust, local partnerships, and persistence are key to lasting impact. Thanks to Kathleen for joining us and for the incredible work she's doing to build the next generation of American engineers!

Welcome to Ozempic Weightloss Unlocked, your podcast for the latest news, research, and practical insights on Ozempic, its medical uses, and the impact on lifestyle and health. Ozempic, known generically as semaglutide, was originally developed for type two diabetes but is now widely prescribed for weight management. According to Women's Health Research Cluster, Ozempic works by mimicking a hormone called glucagon-like peptide-1 that helps you feel fuller longer and slows down how quickly the stomach empties. These effects not only help reduce appetite, but also keep blood sugar stable. That is why demand for these medications has skyrocketed over the past few years.Clinical trials consistently show notable results. Multiple large studies, as summarized in the National Library of Medicine, reveal that up to 14 to 16 percent body weight loss can be sustained for more than a year. Even higher percentages are seen when combined with behavioral therapy and a low-calorie diet. Some studies on similar drugs, like tirzepatide, report weight loss as high as 20 percent over seventy-two weeks. These numbers put Ozempic and its peers at the center of conversation around obesity and metabolic health.Real-world factors do impact results. New York University research presented at the American Society for Metabolic and Bariatric Surgery compared Ozempic and similar drugs to bariatric surgery. Surgery produced five times the weight loss of medication, averaging more than 25 percent body weight lost over two years. Researchers noted that regardless of the method, consistency is key. Medications only work as long as they are taken, while surgery is a permanent change.For those considering Ozempic, there are some noticeable bodily effects. Medical News Today discusses “Ozempic legs,” a term for changes in leg appearance during rapid weight loss, such as thinner or frailer legs and sometimes loose skin. This can result from losing both fat and muscle. Up to forty percent of weight lost on semaglutide may come from lean body mass, not just fat. To address this, experts recommend eating enough protein, incorporating regular strength training, and losing weight gradually to preserve muscle and skin elasticity.Another area of emerging research is how these GLP-1 drugs affect alcohol metabolism. The Fralin Biomedical Research Institute found that medications like Ozempic can slow how quickly alcohol enters the bloodstream, delay its effects on the brain, and potentially reduce alcohol use. These findings suggest the drugs may play a future role in addiction treatment.In terms of safety and tolerability, gastrointestinal symptoms are the most common side effects, such as nausea or upset stomach. These are usually mild or moderate and tend to fade with time. For people with psychiatric conditions such as schizophrenia, data published by National Library of Medicine indicate Ozempic led to significant weight loss without worsening mental health or interfering with medications.When stopping these medications, Women's Health Research Cluster points out weight regain is very likely, as the body's metabolic adaptations revert without continued GLP-1 stimulation. Long-term studies are ongoing to better understand risks and benefits over many years.There is also growing attention on rare, “unusual” side effects. The Independent and other outlets note that advanced imaging scans became necessary to rule out suspicious findings linked to rapid weight changes when doctors were assessing patients on these drugs. Researchers emphasize this does not mean the drugs cause cancer or other conditions, but it is an important side effect to keep monitoring as usage increases.While Ozempic has made headlines as a “miracle” weight loss medication, experts urge listeners to use it as part of a broader lifestyle approach, including healthy eating, physical activity, and regular medical check-ins. As with any medication, speak with your health care provider about the risks, benefits, and whether this option fits your specific goals and conditions.Thanks for tuning in to Ozempic Weightloss Unlocked. Remember to subscribe so you never miss an update on the latest research and real-world experiences on Ozempic and metabolic health. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Desiree Chappell and Lieutenant Colonel Daniel P. Raboin, MD, PharmD, U.S. Army anesthesiologist and pharmacist who serves as the Deputy Anesthesiology Consultant to the Army Surgeon General, Lieutenant Colonel Jordan Lane, MD, U.S. Army anesthesiologist at Tripler Army Medical Center in Hawaii and Colonel Michael S. Patzkowski, MD, MHA, Army Anesthesiology Consultant to the Surgeon General. Recorded at Anesthesiology 2025, the annual meeting of the American Society of Anesthesiologists (ASA) conference in San Antonio, we discuss clinical readiness and training programs within Army anesthesiology, cover the importance of maintaining clinical readiness through specialized training, partnership agreements with civilian trauma centers, and how these programs help in preparing anesthesiologists for deployment situations. The discussion also highlights the logistical and administrative challenges of such programs and the solutions implemented to overcome them.

“Genomic Selection: Essence, Applications, and Prospects” with Dr. Jianming Yu Genomic Selection is a plant breeding innovation that aims to speed plant breeding by using predictions from a training model enabled by genomics and statistics to guide the breeding decisions. With around thirty years of history around this innovation, it was about time to develop a review on it. Enter Dr. Jianming Yu and his team of coauthors. This episode, we skate the surface of a topic that could go down for miles, covering key areas of genomic selection, what it is, how to use it, and where we can aim to go in the future. Tune in to learn: ·         How genomic selection was developed ·         Why genomic selection should be seen as an innovation in rather than alternative to plant breeding ·         Why growing out crosses still matters ·         How AI could be integrated to further genomic selection If you would like more information about this topic, this episode's paper is available here: https://doi.org/10.1002/tpg2.70053 This paper is always freely available. Contact us at podcast@sciencesocieties.org or on Twitter @FieldLabEarth if you have comments, questions, or suggestions for show topics, and if you want more content like this don't forget to subscribe. If you'd like to see old episodes or sign up for our newsletter, you can do so here: https://fieldlabearth.libsyn.com/. If you would like to reach out to Jianming, you can find him here: jmyu@iastate.edu https://www.agron.iastate.edu/people/yu-jianming/ https://www.linkedin.com/in/jianming-yu-92b6617b/ https://www.linkedin.com/company/iowa-state-university-raymond-f-baker-center-for-plant-breeding/ Resources CEU Quiz: https://web.sciencesocieties.org/Learning-Center/Courses/Course-Detail?productid=%7b001D06ED-D9AA-F011-BBD3-000D3A599510%7d  Transcripts: https://www.rev.com/app/captions/NjhlZmI3ODYwMWFmOTFkYzdlYWRiMjhhM29MVTM2MVduOEFD/o/Q1AwNDYyNDc5Mzkz  CSA News article: https://www.sciencesocieties.org/publications/csa-news/2025/november/essence-of-genomic-selection  Field, Lab, Earth is Copyrighted by the American Society of Agronomy, Crop Science Society of America, and Soil Science Society of America.

Anesthesiology 2025, the annual meeting of the American Society of Anesthesiologists. The TopMedTalk team were there and this piece sees Mike Grocott speaking with Sheena Scott, Founder of Scott Healthcare Consulting and Jason Greenberg, Strategic Advisor, Anesthesia, Ventra Health. They discuss common governance mistakes in anesthesiology groups, the importance of effective governance structures, and strategies for improvement. The conversation highlights the challenges of democratic decision-making in larger groups, the need for emotional intelligence in leadership, and methods to address detractors and conflicts. They also emphasize the importance of bylaws, outside consultation, and continued professional development through resources like the ASA's Advance meeting.

An avalanche of information besets us on what to eat. It comes from the news, from influencers of every ilk, from scientists, from government, and of course from the food companies. Super foods? Ultra-processed foods? How does one find a source of trust and make intelligent choices for both us as individuals and for the society as a whole. A new book helps in this quest, a book entitled Food Intelligence: the Science of How Food Both Nourishes and Harms Us. It is written by two highly credible and thoughtful people who join us today.Julia Belluz is a journalist and a contributing opinion writer for the New York Times. She reports on medicine, nutrition, and public health. She's been a Knight Science Journalism Fellow at MIT and holds a master's in science degree from the London School of Economics and Political Science. Dr. Kevin Hall trained as a physicist as best known for pioneering work on nutrition, including research he did as senior investigator and section chief at the National Institutes of Health. His work is highly regarded. He's won awards from the NIH, from the American Society of Nutrition, the Obesity Society and the American Physiological Society. Interview Transcript Thank you both very much for being with us. And not only for being with us, but writing such an interesting book. I was really eager to read it and there's a lot in there that people don't usually come across in their normal journeys through the nutrition world. So, Julia, start off if you wouldn't mind telling us what the impetus was for you and Kevin to do this book with everything else that's out there. Yes, so there's just, I think, an absolute avalanche of information as you say about nutrition and people making claims about how to optimize diet and how best to lose or manage weight. And I think what we both felt was missing from that conversation was a real examination of how do we know what we know and kind of foundational ideas in this space. You hear a lot about how to boost or speed up your metabolism, but people don't know what metabolism is anyway. You hear a lot about how you need to maximize your protein, but what is protein doing in the body and where did that idea come from? And so, we were trying to really pair back. And I think this is where Kevin's physics training was so wonderful. We were trying to look at like what are these fundamental laws and truths. Things that we know about food and nutrition and how it works in us, and what can we tell people about them. And as we kind of went through that journey it very quickly ended up in an argument about the food environment, which I know we're going to get to. We will. It's really interesting. This idea of how do we know what we know is really fascinating because when you go out there, people kind of tell us what we know. Or at least what they think what we know. But very few people go through that journey of how did we get there. And so people can decide on their own is this a credible form of knowledge that I'm being told to pursue. So Kevin, what do you mean by food intelligence? Coming from a completely different background in physics where even as we learn about the fundamental laws of physics, it's always in this historical context about how we know what we know and what were the kind of key experiments along the way. And even with that sort of background, I had almost no idea about what happened to food once we ate it inside our bodies. I only got into this field by a happenstance series of events, which is probably too long to talk about this podcast. But to get people to have an appreciation from the basic science about what is going on inside our bodies when we eat. What is food made out of? As best as we can understand at this current time, how does our body deal with. Our food and with that sort of basic knowledge about how we know what we know. How to not be fooled by these various sound bites that we'll hear from social media influencers telling you that everything that you knew about nutrition is wrong. And they've been hiding this one secret from you that's been keeping you sick for so long to basically be able to see through those kinds of claims and have a bedrock of knowledge upon which to kind of evaluate those things. That's what we mean by food intelligence. It makes sense. Now, I'm assuming that food intelligence is sort of psychological and biological at the same time, isn't it? Because that there's what you're being told and how do you process that information and make wise choices. But there's also an intelligence the body has and how to deal with the food that it's receiving. And that can get fooled too by different things that are coming at it from different types of foods and stuff. We'll get to that in a minute, but it's a very interesting concept you have, and wouldn't it be great if we could all make intelligent choices? Julia, you mentioned the food environment. How would you describe the modern food environment and how does it shape the choices we make? It's almost embarrassing to have this question coming from you because so much of our understanding and thinking about this idea came from you. So, thank you for your work. I feel like you should be answering this question. But I think one of the big aha moments I had in the book research was talking to a neuroscientist, who said the problem in and of itself isn't like the brownies and the pizza and the chips. It's the ubiquity of them. It's that they're most of what's available, along with other less nutritious ultra-processed foods. They're the most accessible. They're the cheapest. They're kind of heavily marketed. They're in our face and the stuff that we really ought to be eating more of, we all know we ought to be eating more of, the fruits and vegetables, fresh or frozen. The legumes, whole grains. They're the least available. They're the hardest to come by. They're the least accessible. They're the most expensive. And so that I think kind of sums up what it means to live in the modern food environment. The deck is stacked against most of us. The least healthy options are the ones that we're inundated by. And to kind of navigate that, you need a lot of resources, wherewithal, a lot of thought, a lot of time. And I think that's kind of where we came out thinking about it. But if anyone is interested in knowing more, they need to read your book Food Fight, because I think that's a great encapsulation of where we still are basically. Well, Julie, it's nice of you to say that. You know what you reminded me one time I was on a panel and a speaker asks the audience, how many minutes do you live from a Dunkin Donuts? And people sort of thought about it and nobody was more than about five minutes from a Dunkin Donuts. And if I think about where I live in North Carolina, a typical place to live, I'm assuming in America. And boy, within about five minutes, 10 minutes from my house, there's so many fast-food places. And then if you add to that the gas stations that have foods and the drug store that has foods. Not to mention the supermarkets. It's just a remarkable environment out there. And boy, you have to have kind of iron willpower to not stop and want that food. And then once it hits your body, then all heck breaks loose. It's a crazy, crazy environment, isn't it? Kevin, talk to us, if you will, about when this food environment collides with human biology. And what happens to normal biological processes that tell us how much we should eat, when we should stop, what we should eat, and things like that. I think that that is one of the newer pieces that we're really just getting a handle on some of the science. It's been observed for long periods of time that if you change a rat's food environment like Tony Sclafani did many, many years ago. That rats aren't trying to maintain their weight. They're not trying to do anything other than eat whatever they feel like. And, he was having a hard time getting rats to fatten up on a high fat diet. And he gave them this so-called supermarket diet or cafeteria diet composed of mainly human foods. And they gained a ton of weight. And I think that pointed to the fact that it's not that these rats lacked willpower or something like that. That they weren't making these conscious choices in the same way that we often think humans are entirely under their conscious control about what we're doing when we make our food choices. And therefore, we criticize people as having weak willpower when they're not able to choose a healthier diet in the face of the food environment. I think the newer piece that we're sort of only beginning to understand is how is it that that food environment and the foods that we eat might be changing this internal symphony of signals that's coming from our guts, from the hormones in our blood, to our brains and the understanding that of food intake. While you might have control over an individual meal and how much you eat in that individual meal is under biological control. And what are the neural systems and how do they work inside our brains in communicating with our bodies and our environment as a whole to shift the sort of balance point where body weight is being regulated. To try to better understand this really intricate interconnection or interaction between our genes, which are very different between people. And thousands of different genes contributing to determining heritability of body size in a given environment and how those genes are making us more or less susceptible to these differences in the food environment. And what's the underlying biology? I'd be lying to say if that we have that worked out. I think we're really beginning to understand that, but I hope what the book can give people is an appreciation for the complexity of those internal signals and that they exist. And that food intake isn't entirely under our control. And that we're beginning to unpack the science of how those interactions work. It's incredibly interesting. I agree with you on that. I have a slide that I bet I've shown a thousand times in talks that I think Tony Sclafani gave me decades ago that shows laboratory rats standing in front of a pile of these supermarket foods. And people would say, well, of course you're going to get overweight if that's all you eat. But animals would eat a healthy diet if access to it. But what they did was they had the pellets of the healthy rat chow sitting right in that pile. Exactly. And the animals ignore that and overeat the unhealthy food. And then you have this metabolic havoc occur. So, it seems like the biology we've all inherited works pretty well if you have foods that we've inherited from the natural environment. But when things become pretty unnatural and we have all these concoctions and chemicals that comprise the modern food environment the system really breaks down, doesn't it? Yeah. And I think that a lot of people are often swayed by the idea as well. Those foods just taste better and that might be part of it. But I think that what we've come to realize, even in our human experiments where we change people's food environments... not to the same extent that Tony Sclafani did with his rats, but for a month at a time where we ask people to not be trying to gain or lose weight. And we match certain food environments for various nutrients of concern. You know, they overeat diets that are higher in these so-called ultra-processed foods and they'd spontaneously lose weight when we remove those from the diet. And they're not saying that the foods are any more or less pleasant to eat. There's this underlying sort of the liking of foods is somewhat separate from the wanting of foods as neuroscientists are beginning to understand the different neural pathways that are involved in motivation and reward as opposed to the sort of just the hedonic liking of foods. Even the simple explanation of 'oh yeah, the rats just like the food more' that doesn't seem to be fully explaining why we have these behaviors. Why it's more complicated than a lot of people make out. Let's talk about ultra-processed foods and boy, I've got two wonderful people to talk to about that topic. Julia, let's start with your opinion on this. So tell us about ultra-processed foods and how much of the modern diet do they occupy? So ultra-processed foods. Obviously there's an academic definition and there's a lot of debate about defining this category of foods, including in the US by the Health and Human Services. But the way I think about it is like, these are foods that contain ingredients that you don't use in your home kitchen. They're typically cooked. Concocted in factories. And they now make up, I think it's like 60% of the calories that are consumed in America and in other similar high-income countries. And a lot of these foods are what researchers would also call hyper palatable. They're crossing these pairs of nutrient thresholds like carbohydrate, salt, sugar, fat. These pairs that don't typically exist in nature. So, for the reasons you were just discussing they seem to be particularly alluring to people. They're again just like absolutely ubiquitous and in these more developed contexts, like in the US and in the UK in particular. They've displaced a lot of what we would think of as more traditional food ways or ways that people were eating. So that's sort of how I think about them. You know, if you go to a supermarket these days, it's pretty hard to find a part of the supermarket that doesn't have these foods. You know, whole entire aisles of processed cereals and candies and chips and soft drinks and yogurts, frozen foods, yogurts. I mean, it's just, it's all over the place. And you know, given that if the average is 60% of calories, and there are plenty of people out there who aren't eating any of that stuff at all. For the other people who are, the number is way higher. And that, of course, is of great concern. So there have been hundreds of studies now on ultra-processed foods. It was a concept born not that long ago. And there's been an explosion of science and that's all for the good, I think, on these ultra-processed foods. And perhaps of all those studies, the one discussed most is one that you did, Kevin. And because it was exquisitely controlled and it also produced pretty striking findings. Would you describe that original study you did and what you found? Sure. So, the basic idea was one of the challenges that we have in nutrition science is accurately measuring how many calories people eat. And the best way to do that is to basically bring people into a laboratory and measure. Give them a test meal and measure how many calories they eat. Most studies of that sort last for maybe a day or two. But I always suspected that people could game the system if for a day or two, it's probably not that hard to behave the way that the researcher wants, or the subject wants to deceive the researcher. We decided that what we wanted to do was bring people into the NIH Clinical Center. Live with us for a month. And in two two-week blocks, we decided that we would present them with two different food environments essentially that both provided double the number of calories that they would require to maintain their body weight. Give them very simple instructions. Eat as much or as little as you'd like. Don't be trying to change your weight. We're not going to tell you necessarily what the study's about. We're going to measure lots of different things. And they're blinded to their weight measurements and they're wearing loose fitting scrubs and things like that, so they can't tell if their clothes are getting tighter or looser. And so, what we did is in for one two-week block, we presented people with the same number of calories, the same amount of sugar and fat and carbs and fiber. And we gave them a diet that was composed of 80% of calories coming from these ultra-processed foods. And the other case, we gave them a diet that was composed of 0% of calories from ultra-processed food and 80% of the so-called minimally processed food group. And what we then did was just measured people's leftovers essentially. And I say we, it was really the chefs and the dieticians at the clinical center who are doing all the legwork on this. But what we found was pretty striking, which was that when people were exposed to this highly ultra-processed food environment, despite being matched for these various nutrients of concern, they overate calories. Eating about 500 calories per day on average, more than the same people in the minimally processed diet condition. And they gained weight and gained body fat. And, when they were in the minimally processed diet condition, they spontaneously lost weight and lost body fat without trying in either case, right? They're just eating to the same level of hunger and fullness and overall appetite. And not reporting liking the meals any more or less in one diet versus the other. Something kind of more fundamental seemed to have been going on that we didn't fully understand at the time. What was it about these ultra-processed foods? And we were clearly getting rid of many of the things that promote their intake in the real world, which is that they're convenient, they're cheap, they're easy to obtain, they're heavily marketed. None of that was at work here. It was something really about the meals themselves that we were providing to people. And our subsequent research has been trying to figure out, okay, well what were the properties of those meals that we were giving to these folks that were composed primarily of ultra-processed foods that were driving people to consume excess calories? You know, I've presented your study a lot when I give talks. It's nice hearing it coming from you rather than me. But a couple of things that interest me here. You use people as their own controls. Each person had two weeks of one diet and two weeks of another. That's a pretty powerful way of providing experimental control. Could you say just a little bit more about that? Yeah, sure. So, when you design a study, you're trying to maximize the efficiency of the study to get the answers that you want with the least number of participants while still having good control and being able to design the study that's robust enough to detect a meaningful effect if it exists. One of the things that you do when you analyze studies like that or design studies like that, you could just randomize people to two different groups. But given how noisy and how different between people the measurement of food intake is we would've required hundreds of people in each group to detect an effect like the one that we discovered using the same person acting as their own control. We would still be doing the study 10 years later as opposed to what we were able to do in this particular case, which is completed in a year or so for that first study. And so, yeah, when you kind of design a study that way it's not always the case that you get that kind of improvement in statistical power. But for a measurement like food intake, it really is necessary to kind of do these sorts of crossover type studies where each person acts as their own control. So put the 500 calorie increment in context. Using the old fashioned numbers, 3,500 calories equals a pound. That'd be about a pound a week or a lot of pounds over a year. But of course, you don't know what would happen if people were followed chronically and all that. But still 500 calories is a whopping increase, it seems to me. It sure is. And there's no way that we would expect it to stay at that constant level for many, many weeks on end. And I think that's one of the key questions going forward is how persistent is that change. And how does something that we've known about and we discuss in our books the basic physiology of how both energy expenditure changes as people gain and lose weight, as well as how does appetite change in a given environment when they gain and lose weight? And how do those two processes eventually equate at a new sort of stable body weight in this case. Either higher or lower than when people started the program of this diet manipulation. And so, it's really hard to make those kinds of extrapolations. And that's of course, the need for further research where you have longer periods of time and you, probably have an even better control over their food environment as a result. I was surprised when I first read your study that you were able to detect a difference in percent body fat in such a short study. Did that surprise you as well? Certainly the study was not powered to detect body fat changes. In other words, we didn't know even if there were real body fat changes whether or not we would have the statistical capabilities to do that. We did use a method, DXA, which is probably one of the most precise and therefore, if we had a chance to measure it, we had the ability to detect it as opposed to other methods. There are other methods that are even more precise, but much more expensive. So, we thought that we had a chance to detect differences there. Other things that we use that we also didn't think that we necessarily would have a chance to detect were things like liver fat or something like that. Those have a much less of an ability. It's something that we're exploring now with our current study. But, again, it's all exploratory at that point. So what can you tell us about your current study? We just wrapped it up, thankfully. What we were doing was basically re-engineering two new ultra-processed diets along parameters that we think are most likely the mechanisms by which ultra-processed meals drove increased energy intake in that study. One was the non-beverage energy density. In other words, how many calories per gram of food on the plate, not counting the beverages. Something that we noticed in the first study was that ultra-processed foods, because they're essentially dried out in the processing for reasons of food safety to prevent bacterial growth and increased shelf life, they end up concentrating the foods. They're disrupting the natural food matrix. They last a lot longer, but as a result, they're a more concentrated form of calories. Despite being, by design, we chose the overall macronutrients to be the same. They weren't necessarily higher fat as we often think of as higher energy density. What we did was we designed an ultra-processed diet that was low in energy density to kind of match the minimally processed diet. And then we also varied the number of individual foods that were deemed hyper palatable according to kind of what Julia said that crossed these pairs of thresholds for fat and sugar or fat and salt or carbs and salt. What we noticed in the first study was that we presented people with more individual foods on the plate that had these hyper palatable combinations. And I wrestle with the term terminology a little bit because I don't necessarily think that they're working through the normal palatability that they necessarily like these foods anymore because again, we asked people to rate the meals and they didn't report differences. But something about those combinations, regardless of what you call them, seemed to be driving that in our exploratory analysis of the first study. We designed a diet that was high in energy density, but low in hyper palatable foods, similar to the minimally processed. And then their fourth diet is with basically low in energy density and hyper palatable foods. And so, we presented some preliminary results last year and what we were able to show is that when we reduced both energy density and the number of hyper palatable foods, but still had 80% of calories from ultra-processed foods, that people more or less ate the same number of calories now as they did when they were the same people were exposed to the minimally processed diet. In fact they lost weight, to a similar extent as the minimally processed diet. And that suggests to me that we can really understand mechanisms at least when it comes to calorie intake in these foods. And that might give regulators, policy makers, the sort of information that they need in order to target which ultra-processed foods and what context are they really problematic. It might give manufacturers if they have the desire to kind of reformulate these foods to understand which ones are more or less likely to cause over consumption. So, who knows? We'll see how people respond to that and we'll see what the final results are with the entire study group that, like I said, just finished, weeks ago. I respond very positively to the idea of the study. The fact that if people assume ultra-processed foods are bad actors, then trying to find out what it is about them that's making the bad actors becomes really important. And you're exactly right, there's a lot of pressure on the food companies now. Some coming from public opinion, some coming from parts of the political world. Some from the scientific world. And my guess is that litigation is going to become a real actor here too. And the question is, what do you want the food industry to do differently? And your study can really help inform that question. So incredibly valuable research. I can't wait to see the final study, and I'm really delighted that you did that. Let's turn our attention for a minute to food marketing. Julia, where does food marketing fit in all this? Julia - What I was very surprised to find while we were researching the book was this deep, long history of calls against marketing junk food in particular to kids. I think from like the 1950s, you have pediatrician groups and other public health professionals saying, stop this. And anyone who has spent any time around small children knows that it works. We covered just like a little, it was from an advocacy group in the UK that exposed aid adolescents to something called Triple Dip Chicken. And then asked them later, pick off of this menu, I think it was like 50 items, which food you want to order. And they all chose Triple Dip chicken, which is, as the name suggests, wasn't the healthiest thing to choose on the menu. I think we know obviously that it works. Companies invest a huge amount of money in marketing. It works even in ways like these subliminal ways that you can't fully appreciate to guide our food choices. Kevin raised something really interesting was that in his studies it was the foods. So, it's a tricky one because it's the food environment, but it's also the properties of the foods themselves beyond just the marketing. Kevin, how do you think about that piece? I'm curious like. Kevin - I think that even if our first study and our second study had turned out there's no real difference between these artificial environments that we've put together where highly ultra-processed diets lead to excess calorie intake. If that doesn't happen, if it was just the same, it wouldn't rule out the fact that because these foods are so heavily marketed, because they're so ubiquitous. They're cheap and convenient. And you know, they're engineered for many people to incorporate into their day-to-day life that could still promote over consumption of calories. We just remove those aspects in our very artificial food environment. But of course, the real food environment, we're bombarded by these advertisements and the ubiquity of the food in every place that you sort of turn. And how they've displaced healthy alternatives, which is another mechanism by which they could cause harm, right? It doesn't even have to be the foods themselves that are harmful. What do they displace? Right? We only have a certain amount the marketers called stomach share, right? And so, your harm might not be necessarily the foods that you're eating, but the foods that they displaced. So even if our experimental studies about the ultra-processed meals themselves didn't show excess calorie intake, which they clearly did, there's still all these other mechanisms to explore about how they might play a part in the real world. You know, the food industry will say that they're agnostic about what foods they sell. They just respond to demand. That seems utter nonsense to me because people don't overconsume healthy foods, but they do overconsume the unhealthy ones. And you've shown that to be the case. So, it seems to me that idea that they can just switch from this portfolio of highly processed foods to more healthy foods just doesn't work out for them financially. Do you think that's right? I honestly don't have that same sort of knee jerk reaction. Or at least I perceive it as a knee jerk reaction, kind of attributing malice in some sense to the food industry. I think that they'd be equally happy if they could get you to buy a lot and have the same sort of profit margins, a lot of a group of foods that was just as just as cheap to produce and they could market. I think that you could kind of turn the levers in a way that that would be beneficial. I mean, setting aside for example, that diet soda beverages are probably from every randomized control trial that we've seen, they don't lead to the same amount of weight gain as the sugar sweetened alternatives. They're just as profitable to the beverage manufacturers. They sell just as many of them. Now they might have other deleterious consequences, but I don't think that it's necessarily the case that food manufacturers have to have these deleterious or unhealthy foods as their sole means of attaining profit. Thanks for that. So, Julia, back to you. You and Kevin point out in your book some of the biggest myths about nutrition. What would you say some of them are? I think one big, fundamental, overarching myth is this idea that the problem is in us. That this rise of diet related diseases, this explosion that we've seen is either because of a lack of willpower. Which you have some very elegant research on this that we cite in the book showing willpower did not collapse in the last 30, 40 years of this epidemic of diet related disease. But it's even broader than that. It's a slow metabolism. It's our genes. Like we put the problem on ourselves, and we don't look at the way that the environment has changed enough. And I think as individuals we don't do that. And so much of the messaging is about what you Kevin, or you Kelly, or you Julia, could be doing better. you know, do resistance training. Like that's the big thing, like if you open any social media feed, it's like, do more resistance training, eat more protein, cut out the ultra-processed foods. What about the food environment? What about the leaders that should be held accountable for helping to perpetuate these toxic food environments? I think that that's this kind of overarching, this pegging it and also the rise of personalized nutrition. This like pegging it to individual biology instead of for whatever the claim is, instead of thinking about how did environments and don't want to have as part of our lives. So that's kind of a big overarching thing that I think about. It makes sense. So, let's end on a positive note. There's a lot of reason to be concerned about the modern food environment. Do you see a helpful way forward and what might be done about this? Julia, let's stay with you. What do you think? I think so. We spent a lot of time researching history for this book. And a lot of things that seem impossible are suddenly possible when you have enough public demand and enough political will and pressure. There are so many instances and even in the history of food. We spend time with this character Harvey Wiley, who around the turn of the century, his research was one of the reasons we have something like the FDA protecting the food supply. That gives me a lot of hope. And we are in this moment where a lot of awareness is being raised about the toxic food environment and all these negative attributes of food that people are surrounded by. I think with enough organization and enough pressure, we can see change. And we can see this kind of flip in the food environment that I think we all want to see where healthier foods become more accessible, available, affordable, and the rest of it. Sounds good. Kevin, what are your thoughts? Yes, I just extend that to saying that for the first time in history, we sort of know what the population of the planet is going to be that we have to feed in the future. We're not under this sort of Malthusian threat of not being able to know where the population growth is going to go. We know it's going to be roughly 10 billion people within the next century. And we know we've got to change the way that we produce and grow food for the planet as well as for the health of people. We know we've got to make changes anyway. And we're starting from a position where per capita, we're producing more protein and calories than any other time in human history, and we're wasting more food. We actually know we're in a position of strength. We don't have to worry so acutely that we won't be able to provide enough food for everybody. It's what kind of food are we going to produce? How are we going to produce it in the way that's sustainable for both people and the planet? We have to tackle that anyway. And for the folks who had experienced the obesity epidemic or finally have drugs to help them and other kinds of interventions to help them. That absolve them from this idea that it's just a matter of weak willpower if we finally have some pharmaceutical interventions that are useful. So, I do see a path forward. Whether or not we take that is another question. Bios Dr. Kevin Hall is the section chief of Integrative Physiology Section in the Laboratory of Biological Modeling at the NIH National Institute of Diabetes and Digestive and Kidney Diseases. Kevin's laboratory investigates the integrative physiology of macronutrient metabolism, body composition, energy expenditure, and control of food intake. His main goal is to better understand how the food environment affects what we eat and how what we eat affects our physiology. He performs clinical research studies as well as developing mathematical models and computer simulations to better understand physiology, integrate data, and make predictions. In recent years, he has conducted randomized clinical trials to study how diets high in ultra-processed food may cause obesity and other chronic diseases. He holds a Ph.D. from McGill University. Julia Belluz is a Paris-based journalist and a contributing opinion writer to the New York Times, she has reported extensively on medicine, nutrition, and global public health from Canada, the US, and Europe. Previously, Julia was Vox's senior health correspondent in Washington, DC, a Knight Science Journalism fellow at the Massachusetts Institute of Technology in Cambridge, and she worked as a reporter in Toronto and London. Her writing has appeared in a range of international publications, including the BMJ, the Chicago Tribune, the Economist, the Globe and Mail, Maclean's, the New York Times, ProPublica, and the Times of London. Her work has also had an impact, helping improve policies on maternal health and mental healthcare for first responders at the hospital- and state-level, as well as inspiring everything from scientific studies to an opera. Julia has been honored with numerous journalism awards, including the 2016 Balles Prize in Critical Thinking, the 2017 American Society of Nutrition Journalism Award, and three Canadian National Magazine Awards (in 2007 and 2013). In 2019, she was a National Academies of Sciences, Engineering, and Medicine Communications Award finalist. She contributed chapters on public health journalism in the Tactical Guide to Science Journalism, To Save Humanity: What Matters Most for a Healthy Future, and was a commissioner for the Global Commission on Evidence to Address Societal Challenges.

Pain Exam Podcast  Recent Conference Activities London Conference Weekend: Successfully attended and spoke at ISPN and SOMOS care conferences Somos Care Conference: Delivered presentation on pain management for primary care physicians Presentation consisted of 50+ slides with only one slide dedicated to opiates Emphasized shift away from opiate-based treatments in interventional pain management Recommended primary care physicians refer patients to pain specialists for comprehensive treatment options ISPN Conference: Participated in international pain management conference Met with doctors from London, Iraq, and various other countries Observed different international approaches to pain treatment including increased phenol use and varying regenerative medicine restrictions Upcoming Events and Workshops New York-New Jersey Pain Conference: November (NRAP Academy booth presence) IV Ultrasound Placement Workshops: Monthly sessions in New York Regional Anesthesia and Ultrasound-Guided Interventional Pain Medicine Workshops: New York: December 13th, January 10th Florida (Fort Lauderdale/Hollywood): November 8th Detroit: January 18th, February 15th Alternative Options: Online ultrasound courses and shadowing opportunities available Board Prep and NRAP Community at PainExam.com or NRAPpain.org ABA ABPM ABIPP FIPP Pain Management Board prep, Question Banks, and Virtual Pain Fellowship Educational Offerings and Events Training and Courses: Research Review: ACL Treatment Study Study Focus: Non-surgical treatment of ACL tears using bone marrow concentrate (BMAC) and platelet products versus exercise therapy Key Findings: BMAC group showed significantly greater improvement in Lower Extremity Function Scale (LEFS) and Single Assessment Numeric Evaluation (SANE) scores at three months Sustained improvement in function and decreased pain maintained through two-year follow-up Patients reported median subjective improvement of 90% at final follow-up No significant improvements observed in exercise-only group during initial three months Treatment Protocol: Bone marrow harvest from posterior superior iliac crest (60-90ml from 6-8 sites) PRP preparation from 60ml whole blood Fluoroscopy-guided injection directly into ACL ligament Comprehensive 52-week rehabilitation protocol with activity restrictions Clinical Practice Implications Current ACL Treatment Landscape: Over 400,000 ACL reconstruction surgeries performed annually in the US Surgical Limitations: Risk of graft failure, persistent instability, cartilage injury, and increased arthritis risk Return to Sport Statistics: Post-surgical rates vary significantly (33-92% return to sport, 65% return to pre-injury level) Practice Integration Considerations: Potential incorporation of BMAC/PRP protocols for ACL tears, though insurance coverage remains limited   David Rosenblum, MD, currently serves as the Director of Pain Management at Maimonides Medical Center and AABP Integrative Pain Care.  As a member of the Department of Anesthesiology, he is involved in teaching, research, CME activities, and was key faculty in developing the anesthesiology residency's regional anesthesia block rotation, as well as institutional wide acute and chronic pain management protocols to ensure safe and effective pain management. He currently is a managing partner in a multi-physician private pain practice, AABP Integrative Pain Care, located in Brooklyn, NY. He is one of the earliest interventional pain physicians to integrate ultrasound guidance to improve the safety and accuracy of interventional pain procedures.   Awards New York Magazine: Top Doctors: 2016, 2017, 2018, 2021, 2022, 2023, 2024, 2025 Schneps Media: 2015, 2016, 2017, 2019, 2020 Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023 2025 Schneps Media - Brooklyn Courier Life: 2021, 2022, 2023   Dr. Rosenblum written several book chapters on Peripheral Neuromodulation, Radiofrequency Ablation, and Pharmacology.  He has published numerous noteworthy articles and most recently is developing the ASIPP Guidelines for Peripheral Neuromodulation in the treatment of chronic pain. He has been named several times in NY Magazine's Best Pain Management Doctor List, Nassau County's Best Pain Physician, has appeared on NY1 News, and has made several appearances on XM Radio's Doctor Talk. He currently is lecturing on a national and international level and has partnered with the American Society of Interventional Pain Physicians (ASIPP), American Society of Pain and Neuroscience (ASPN), IASP Mexican Chapter, Eastern Pain Association (EPA), the North American Neuromodulation Society (NANS), World Academy of Pain Medicine United, as well as various other organizations, to support educational events and develop new courses. Since 2008, he has helped over 3000 physicians pass the Pain Management Boards, and has been at the forefront of utilizing ultrasound guidance to perform pain procedures.  He now hosts the PainExam podcast, AnesthesiaExam Podcast, PMRExam Podcasts and uses this platform to promote the safe and effective use of ultrasound in the performance of various procedures such as Peripheral Nerve Stimulation, Caudal Epidurals, Selective Nerve Root Blocks, Cluneal Nerve Blocks, Ganglion impar Blocks, Stellate Ganglion Blocks, Brachial Plexus Blocks, Joint Injections and much more!   Doctor Rosenblum created the NRAP (Neuromodulation Regional Anesthesia and Pain) Academy  and travels to teach various courses focused on Pain Medicine, Regenerative Medicine, Ultrasound Guided Pain Procedures and Regional Anesthesia Techniques.    Dr. Rosenblum is persistent when it comes to eliminating pain and has gained a reputation among his patients for thinking "outside the box" and implements ultrasound guidance to deposit medications, biologics (PRP, Bone Marrow Aspirate, etc.) and Peripheral Nerve Stimulators near pain generators. He is currently treating patients in his great neck and Brooklyn office.  For an appointment go to AABPpain.com or call Brooklyn     718 436 7246 References Centeno CJ, Berger DR, Pitts J, Markle J, Pelle AJ, Murphy M, Dodson E. Non-surgical treatment of anterior cruciate ligament tears with percutaneous bone marrow concentrate and platelet products versus exercise therapy: a randomized-controlled, crossover trial with 2-year follow-up. BMC Musculoskelet Disord. 2025 Sep 30;26(1):882. doi: 10.1186/s12891-025-09153-2. PMID: 41029301; PMCID: PMC12486544.   #pccwindsor #paincareclinicswindsor #painwindsorontario #paindocwindsorontarior #paincareclinics #prpwindsorontario #prp #aabppain 

Pain Exam Podcast  Recent Conference Activities London Conference Weekend: Successfully attended and spoke at ISPN and SOMOS care conferences Somos Care Conference: Delivered presentation on pain management for primary care physicians Presentation consisted of 50+ slides with only one slide dedicated to opiates Emphasized shift away from opiate-based treatments in interventional pain management Recommended primary care physicians refer patients to pain specialists for comprehensive treatment options ISPN Conference: Participated in international pain management conference Met with doctors from London, Iraq, and various other countries Observed different international approaches to pain treatment including increased phenol use and varying regenerative medicine restrictions Upcoming Events and Workshops New York-New Jersey Pain Conference: November (NRAP Academy booth presence) IV Ultrasound Placement Workshops: Monthly sessions in New York Regional Anesthesia and Ultrasound-Guided Interventional Pain Medicine Workshops: New York: December 13th, January 10th Florida (Fort Lauderdale/Hollywood): November 8th Detroit: January 18th, February 15th Alternative Options: Online ultrasound courses and shadowing opportunities available Board Prep and NRAP Community at PainExam.com or NRAPpain.org ABA ABPM ABIPP FIPP Pain Management Board prep, Question Banks, and Virtual Pain Fellowship Educational Offerings and Events Training and Courses: Research Review: ACL Treatment Study Study Focus: Non-surgical treatment of ACL tears using bone marrow concentrate (BMAC) and platelet products versus exercise therapy Key Findings: BMAC group showed significantly greater improvement in Lower Extremity Function Scale (LEFS) and Single Assessment Numeric Evaluation (SANE) scores at three months Sustained improvement in function and decreased pain maintained through two-year follow-up Patients reported median subjective improvement of 90% at final follow-up No significant improvements observed in exercise-only group during initial three months Treatment Protocol: Bone marrow harvest from posterior superior iliac crest (60-90ml from 6-8 sites) PRP preparation from 60ml whole blood Fluoroscopy-guided injection directly into ACL ligament Comprehensive 52-week rehabilitation protocol with activity restrictions Clinical Practice Implications Current ACL Treatment Landscape: Over 400,000 ACL reconstruction surgeries performed annually in the US Surgical Limitations: Risk of graft failure, persistent instability, cartilage injury, and increased arthritis risk Return to Sport Statistics: Post-surgical rates vary significantly (33-92% return to sport, 65% return to pre-injury level) Practice Integration Considerations: Potential incorporation of BMAC/PRP protocols for ACL tears, though insurance coverage remains limited   David Rosenblum, MD, currently serves as the Director of Pain Management at Maimonides Medical Center and AABP Integrative Pain Care.  As a member of the Department of Anesthesiology, he is involved in teaching, research, CME activities, and was key faculty in developing the anesthesiology residency's regional anesthesia block rotation, as well as institutional wide acute and chronic pain management protocols to ensure safe and effective pain management. He currently is a managing partner in a multi-physician private pain practice, AABP Integrative Pain Care, located in Brooklyn, NY. He is one of the earliest interventional pain physicians to integrate ultrasound guidance to improve the safety and accuracy of interventional pain procedures.   Awards New York Magazine: Top Doctors: 2016, 2017, 2018, 2021, 2022, 2023, 2024, 2025 Schneps Media: 2015, 2016, 2017, 2019, 2020 Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023 2025 Schneps Media - Brooklyn Courier Life: 2021, 2022, 2023   Dr. Rosenblum written several book chapters on Peripheral Neuromodulation, Radiofrequency Ablation, and Pharmacology.  He has published numerous noteworthy articles and most recently is developing the ASIPP Guidelines for Peripheral Neuromodulation in the treatment of chronic pain. He has been named several times in NY Magazine's Best Pain Management Doctor List, Nassau County's Best Pain Physician, has appeared on NY1 News, and has made several appearances on XM Radio's Doctor Talk. He currently is lecturing on a national and international level and has partnered with the American Society of Interventional Pain Physicians (ASIPP), American Society of Pain and Neuroscience (ASPN), IASP Mexican Chapter, Eastern Pain Association (EPA), the North American Neuromodulation Society (NANS), World Academy of Pain Medicine United, as well as various other organizations, to support educational events and develop new courses. Since 2008, he has helped over 3000 physicians pass the Pain Management Boards, and has been at the forefront of utilizing ultrasound guidance to perform pain procedures.  He now hosts the PainExam podcast, AnesthesiaExam Podcast, PMRExam Podcasts and uses this platform to promote the safe and effective use of ultrasound in the performance of various procedures such as Peripheral Nerve Stimulation, Caudal Epidurals, Selective Nerve Root Blocks, Cluneal Nerve Blocks, Ganglion impar Blocks, Stellate Ganglion Blocks, Brachial Plexus Blocks, Joint Injections and much more!   Doctor Rosenblum created the NRAP (Neuromodulation Regional Anesthesia and Pain) Academy  and travels to teach various courses focused on Pain Medicine, Regenerative Medicine, Ultrasound Guided Pain Procedures and Regional Anesthesia Techniques.    Dr. Rosenblum is persistent when it comes to eliminating pain and has gained a reputation among his patients for thinking "outside the box" and implements ultrasound guidance to deposit medications, biologics (PRP, Bone Marrow Aspirate, etc.) and Peripheral Nerve Stimulators near pain generators. He is currently treating patients in his great neck and Brooklyn office.  For an appointment go to AABPpain.com or call Brooklyn     718 436 7246 References Centeno CJ, Berger DR, Pitts J, Markle J, Pelle AJ, Murphy M, Dodson E. Non-surgical treatment of anterior cruciate ligament tears with percutaneous bone marrow concentrate and platelet products versus exercise therapy: a randomized-controlled, crossover trial with 2-year follow-up. BMC Musculoskelet Disord. 2025 Sep 30;26(1):882. doi: 10.1186/s12891-025-09153-2. PMID: 41029301; PMCID: PMC12486544.   #pccwindsor #paincareclinicswindsor #painwindsorontario #paindocwindsorontarior #paincareclinics #prpwindsorontario #prp #aabppain 

Pain Exam Podcast  Recent Conference Activities London Conference Weekend: Successfully attended and spoke at ISPN and SOMOS care conferences Somos Care Conference: Delivered presentation on pain management for primary care physicians Presentation consisted of 50+ slides with only one slide dedicated to opiates Emphasized shift away from opiate-based treatments in interventional pain management Recommended primary care physicians refer patients to pain specialists for comprehensive treatment options ISPN Conference: Participated in international pain management conference Met with doctors from London, Iraq, and various other countries Observed different international approaches to pain treatment including increased phenol use and varying regenerative medicine restrictions Upcoming Events and Workshops New York-New Jersey Pain Conference: November (NRAP Academy booth presence) IV Ultrasound Placement Workshops: Monthly sessions in New York Regional Anesthesia and Ultrasound-Guided Interventional Pain Medicine Workshops: New York: December 13th, January 10th Florida (Fort Lauderdale/Hollywood): November 8th Detroit: January 18th, February 15th Alternative Options: Online ultrasound courses and shadowing opportunities available Board Prep and NRAP Community at PainExam.com or NRAPpain.org ABA ABPM ABIPP FIPP Pain Management Board prep, Question Banks, and Virtual Pain Fellowship Educational Offerings and Events Training and Courses: Research Review: ACL Treatment Study Study Focus: Non-surgical treatment of ACL tears using bone marrow concentrate (BMAC) and platelet products versus exercise therapy Key Findings: BMAC group showed significantly greater improvement in Lower Extremity Function Scale (LEFS) and Single Assessment Numeric Evaluation (SANE) scores at three months Sustained improvement in function and decreased pain maintained through two-year follow-up Patients reported median subjective improvement of 90% at final follow-up No significant improvements observed in exercise-only group during initial three months Treatment Protocol: Bone marrow harvest from posterior superior iliac crest (60-90ml from 6-8 sites) PRP preparation from 60ml whole blood Fluoroscopy-guided injection directly into ACL ligament Comprehensive 52-week rehabilitation protocol with activity restrictions Clinical Practice Implications Current ACL Treatment Landscape: Over 400,000 ACL reconstruction surgeries performed annually in the US Surgical Limitations: Risk of graft failure, persistent instability, cartilage injury, and increased arthritis risk Return to Sport Statistics: Post-surgical rates vary significantly (33-92% return to sport, 65% return to pre-injury level) Practice Integration Considerations: Potential incorporation of BMAC/PRP protocols for ACL tears, though insurance coverage remains limited   David Rosenblum, MD, currently serves as the Director of Pain Management at Maimonides Medical Center and AABP Integrative Pain Care.  As a member of the Department of Anesthesiology, he is involved in teaching, research, CME activities, and was key faculty in developing the anesthesiology residency's regional anesthesia block rotation, as well as institutional wide acute and chronic pain management protocols to ensure safe and effective pain management. He currently is a managing partner in a multi-physician private pain practice, AABP Integrative Pain Care, located in Brooklyn, NY. He is one of the earliest interventional pain physicians to integrate ultrasound guidance to improve the safety and accuracy of interventional pain procedures.   Awards New York Magazine: Top Doctors: 2016, 2017, 2018, 2021, 2022, 2023, 2024, 2025 Schneps Media: 2015, 2016, 2017, 2019, 2020 Top Doctors New York Metro Area (digital guide): 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023 2025 Schneps Media - Brooklyn Courier Life: 2021, 2022, 2023   Dr. Rosenblum written several book chapters on Peripheral Neuromodulation, Radiofrequency Ablation, and Pharmacology.  He has published numerous noteworthy articles and most recently is developing the ASIPP Guidelines for Peripheral Neuromodulation in the treatment of chronic pain. He has been named several times in NY Magazine's Best Pain Management Doctor List, Nassau County's Best Pain Physician, has appeared on NY1 News, and has made several appearances on XM Radio's Doctor Talk. He currently is lecturing on a national and international level and has partnered with the American Society of Interventional Pain Physicians (ASIPP), American Society of Pain and Neuroscience (ASPN), IASP Mexican Chapter, Eastern Pain Association (EPA), the North American Neuromodulation Society (NANS), World Academy of Pain Medicine United, as well as various other organizations, to support educational events and develop new courses. Since 2008, he has helped over 3000 physicians pass the Pain Management Boards, and has been at the forefront of utilizing ultrasound guidance to perform pain procedures.  He now hosts the PainExam podcast, AnesthesiaExam Podcast, PMRExam Podcasts and uses this platform to promote the safe and effective use of ultrasound in the performance of various procedures such as Peripheral Nerve Stimulation, Caudal Epidurals, Selective Nerve Root Blocks, Cluneal Nerve Blocks, Ganglion impar Blocks, Stellate Ganglion Blocks, Brachial Plexus Blocks, Joint Injections and much more!   Doctor Rosenblum created the NRAP (Neuromodulation Regional Anesthesia and Pain) Academy  and travels to teach various courses focused on Pain Medicine, Regenerative Medicine, Ultrasound Guided Pain Procedures and Regional Anesthesia Techniques.    Dr. Rosenblum is persistent when it comes to eliminating pain and has gained a reputation among his patients for thinking "outside the box" and implements ultrasound guidance to deposit medications, biologics (PRP, Bone Marrow Aspirate, etc.) and Peripheral Nerve Stimulators near pain generators. He is currently treating patients in his great neck and Brooklyn office.  For an appointment go to AABPpain.com or call Brooklyn     718 436 7246 References Centeno CJ, Berger DR, Pitts J, Markle J, Pelle AJ, Murphy M, Dodson E. Non-surgical treatment of anterior cruciate ligament tears with percutaneous bone marrow concentrate and platelet products versus exercise therapy: a randomized-controlled, crossover trial with 2-year follow-up. BMC Musculoskelet Disord. 2025 Sep 30;26(1):882. doi: 10.1186/s12891-025-09153-2. PMID: 41029301; PMCID: PMC12486544.   #pccwindsor #paincareclinicswindsor #painwindsorontario #paindocwindsorontarior #paincareclinics #prpwindsorontario #prp #aabppain 

HPAC On The Air welcomes back the president of the American Society of Plumbing Engineers to give us a halftime report on his two-year term in office. Much is happening regarding codes and infrastructure repairs, he says, but the key to it all will be project team-building and multi-discipline collaboration.

In POWER METAL, award-winning journalist Vince Beiser chronicles the destructive side effects that the global hunt for critical metals has on our clean energy transition, from environmental damage to political upheaval to murder. Vince Beiser is an award-winning journalist and author of “The World in a Grain: The Story of Sand and How It Transformed Civilization.” The book has been translated into five languages, was a finalist for a PEN America award and a California Book Award, and spawned a TEDx talk. Vince is currently at work on a new book, “Power Metal”, about how the materials we need for digital technology and renewable energy are causing environmental havoc, political upheaval, mayhem and murder—and how we can do better.Vince has reported from over 100 countries, states, provinces, kingdoms, occupied territories, no man's lands and disaster zones. He has exposed conditions in California's harshest prisons, trained with troops bound for Iraq, ridden with the first responders to natural disasters, and hunted down other stories from around the world for publications including Wired, The Atlantic, Harper's, Time, The Guardian, Mother Jones, Playboy, Rolling Stone, The Los Angeles Times, The Wall Street Journal, and The New York Times.Vince's work has been honored by Investigative Reporters and Editors, the Society of Professional Journalists, the American Society of Journalists and Authors, the Columbia, Medill and Missouri Graduate Schools of Journalism, and many other institutions. He has three times been part of a team that won the National Magazine Award for General Excellence, and shared in an Emmy for his work with the PBS TV series SoCal Connected. He is also a grantee of the Pulitzer Center on Crisis Reporting.⁠⁠https://vincebeiser.com/⁠⁠⁠⁠https://nexuspmg.com/⁠

What is the future of the EA profession? In short: Strategic executive operations supercharged by AI. Melissa Peoples breaks it down. Recorded at EA Ignite Spring 2025 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Jan Golden is a one-woman force when it comes to changing how the media and greeting card agencies represent aging. For 4 years, Age-Friendly Vibes has featured cards, buttons, stickers and prints that reflect pro-aging sentiments. Active in the American Society on Aging, Changing the Narrative and the American Greeting Card Association, Jan's passion to revolutionize how older people are represented on greeting cards is making waves. Influencers in her pursuit include Ashton Applewhite, Dr. Becca Levy, Jeannine Vanderberg (and Women Over 70-Aging Reimagined). She has 120 designs in many different categories and her cards are on the shelves at Barnes and Noble and Paper Source. "Negative self-talk and deprecating humor are harmful, but reversible." - Jan Golden Connect with Jan: E. Jan@Age-FriendlyVibes.com W. Age-FriendlyVibes.com

My guest today is Bailey Sanders, a Visiting Assistant Professor of Law at Duke University. Her work examines how market competition can advance gender equality and the critical role of women's representation in law and politics. Her research bridges antitrust, constitutional law, and gender equity, and has appeared or is forthcoming in leading law reviews and peer-reviewed journals. She is also co-author of The Fundamental Voter: American Electoral Democracy, 1952–2020 (Oxford University Press, 2024).Sanders received her JD and PhD in Political Science from Duke University before clerking for Judge Gerald B. Tjoflat on the U.S. Court of Appeals for the Eleventh Circuit and practicing in the antitrust group at McDermott Will & Emery in Washington, D.C. Most importantly, she was my student at Duke Law School during the height of Covid, and one of the few bright spots in my zoom day. She joins us today to discuss her paper, Religious Riders and the Sherman Act, forthcoming in the Michigan Law Review. This episode is co-hosted by UVA Law 2Ls Sari Mithal and Cindy Tran.Show NotesAbout Bailey SandersAbout Kim KrawiecAbout Sari MithalAbout Cindy TranSanders, Bailey, Religious Riders and the Sherman Act (January 01, 2024). Michigan Law Review, Forthcoming. Bailey Sanders, Barak Richman, and Kierra B. Jones, “Growing Market Power Among Catholic Hospitals Restrains Access to Reproductive Health Care”, American Progress (SEP 29, 2025)Bailey Sanders, “The Price of Fertility: Egg Donor Compensation in the United States Following Kamakahi v. The American Society for Reproductive Medicine,” Houston Journal of Health Law and Policy, Vol. 22 (2022)Kimberly D. Krawiec, Sunny Samaritans and Egomaniacs: Price-Fixing in the Gamete Market, Law and Contemporary Problems, Vol. 72, No. 3, 2009. Kimberly D. Krawiec, Gametes: Commodification and The Fertility Industry, The Routledge Handbook of Commodification, Vida Panitch and Elodie Bertrand eds., 2023.

Can any physician pivot to open a ketamine clinic, and what does it take to do it safely?In this Echo Episode, Dr. Andrea Austin continues her conversation with Dr. Kim Chan Ko, about common questions on ketamine infusions for mood disorders and chronic pain. As an ophthalmologist turned creative director for her emergency physician husband's clinic, Kim shares insights on transitioning careers, required training, and ethical considerations. She discusses building a patient-centered practice, managing risks like emergencies and addiction, and navigating business challenges while prioritizing family and values.You'll hear how they:Clarify licensing and training needs for ketamine clinics, emphasizing specialties like emergency medicine, anesthesia, and psychiatry  Address safety protocols, including emergency preparedness, patient monitoring, and addiction risk management Explore staffing requirements, from nurses to administrative roles, and marketing strategies for attracting patients Inspire physician entrepreneurs with tips on balancing business with personal life, values alignment, and avoiding burnout through intentional pivotsIf you're a physician considering ketamine therapy or entrepreneurial ventures, this episode provides honest FAQs and strategies for ethical, sustainable change.About the Guest“Action brings clarity.” – Dr. Kim Chan koDr. Kim Chan Ko is a board-certified ophthalmologist, diplomat of the American College of Lifestyle Medicine, and co-founder of Ketamine Startup, an online course teaching physicians to open ketamine infusion clinics. After years as creative director of Reset Ketamine in Palm Springs, CA, alongside her emergency physician husband, Kim stepped away from academic ophthalmology to pursue a path aligned with her passions for patient education, mentorship, and innovative healthcare. Her journey through burnout and coaching has shaped her mission to help physicians find clarity and build fulfilling careers.

Dr Akila Viswanathan speaks with Johns Hopkins Radiation Oncology and Molecular Radiation Sciences faculty in attendance at the 2025 American Society for Radiation Oncology Annual Meeting in San Francisco to review the conference and provide updates on how the information presented will impact patient care. Dr Sahaja Acharya discusses soft tissue sarcomas. Dr Daniel Song reviews a range of studies on prostate cancer. Dr Ana Kiess describes the current state of radiopharmacueticals.  Dr Lawrence Kleinberg updates the progress being made in the treatment of central nervous system malignancies.

In the summer of 1878, eighteen-year-old Esther Cox was assaulted at gunpoint by a male acquaintance, leaving the Nova Scotia teenager traumatized and afraid. In the days that followed, Esther and those with whom she shared a house in rural Amherst began to notice unusual things occurring around the house including knocking on the walls and floors, objects flying around the house, and Esther suffering frequent seizures without any apparent cause.In the months and years that followed, the “Great Amherst Mystery,” as it came to be known, was investigated by various clergy, scientists, and paranormal investigators, all intent on proving or disproving the poltergeist activity. While none of the investigators were ever able to identify the origins of the haunting in the Cox house, the attention made Esther a prominent national figure in spiritualist circles until several bad experiences led her to flee Canada for good several years later.Thank you to the incredible Dave White for research and writing assistance!ReferencesAllen, Alexander. 1970. "Strange to relate." Windsor Star, August 22: 32.Bird, Will R. 1932. "The Great Amherst Mystery." Star Weekly (Toronto, ON), November 19: 28.Hamilton Spectator. 1878. "Spiritualism or diabolism ." Hamilton Spectator (Hamilton, ON), November 22: 4.Hubbell, Walter. 1916. The Great Amherst Mystery: A True Narrative of the Supernatural. New York, NY: Brentano Publishing .Moncton Dispatch. 1879. "The Amherst mystery." Moncton Dispatch, June 18: 1.Ottawa Daily Citizen. 1878. "The Amherst mystery." Ottaway Daily Citizen, November 23: 1.Prince, Walter. 1919. "A Critical Study of 'The Great Amherst Mystery'." Journal of the American Society for Psychical Research 89-130.Smith, Emma. 2022. The haunting of Esther Cox is still a mystery in Amherst. October 20. Accessed October 7, 2025. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This was a conversation with Heath Carter, historian and author of Union Made: Working People and the Rise of Social Christianity in Chicago. Heath walked us through his journey from growing up in evangelical Orange County to discovering a working-class theological tradition that has been largely erased from our collective memory. We explored how the social gospel wasn't born in elite seminaries but was hammered out by workers quoting scripture in union halls, threatening to leave churches that sided with their bosses, and forcing institutional Christianity to reckon with inequality. Heath traced how both Protestant and Catholic churches went from being uniformly anti-labor in the late 1800s to embracing living wages and collective bargaining by the New Deal era—not because theologians had brilliant insights, but because grassroots pressure made it pragmatically and theologically untenable to ignore the labor question. We discussed why this tradition was gutted in the late 20th century, what UAW President Sean Fain's evangelical faith reveals about what's still possible, and whether democracy can survive when we continually compromise democratic values for market demands. Heath reminded us that 1877 was also a catastrophically bad year in American history, but out of that devastation came movements that actually changed things—not through perfect strategies or ideological purity, but through small, faithful acts and found solidarity that transformed institutional incentives. It's a story we desperately need to remember right now. Heath W. Carter is associate professor of American Christianity at Princeton Theological Seminary, where he teaches and writes about the intersection of Christianity and American public life. Carter is the author of Union Made: Working People and the Rise of Social Christianity in Chicago, which was the runner-up for the American Society of Church History's 2015 Brewer Prize. He is also the co-editor of three books: The Pew and the Picket Line: Christianity and the American Working Class, Turning Points in the History of American Evangelicalism, and A Documentary History of Religion in America, 4th Ed. ONLINE CLASS - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The God of Justice: Where Ancient Wisdom Meets Contemporary Longing⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Join John Dominic Crossan, Peter Enns, Casey Sigmon, Aizaiah Yong, & Malcolm Foley As always, the class is donation-based, including 0. INFO & Sign-Up at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.FaithAndPolitics.net⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Theology Beer Camp ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠is a unique three-day conference that brings together of theology nerds and craft beer for a blend of intellectual engagement, community building, and fun. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Get info and tickets here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. _____________________ This podcast is a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Homebrewed Christianity⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ production. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠the Homebrewed Christianity⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Theology Nerd Throwdown⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, & ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Rise of Bonhoeffer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ podcasts for more theological goodness for your earbuds. Join over 75,000 other people by joining our⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Substack - Process This!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get instant access to over 50 classes at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.TheologyClass.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow the podcast, drop a review⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, send ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠feedback/questions⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or become a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠member of the HBC Community⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dwight D. Eisenhower was born in Denison, Texas, in 1890. He was the President of the United States when I was born in Dallas, Texas, 68 years later.People called me “Little Roy.” People called him “Ike.”I worry that we have forgotten him.Ike Eisenhower graduated from the United States Military Academy in 1915 when he was 24 years old. His superiors noticed his organizational abilities, and appointed him commander of a tank training center during World War I.In 1933, he became aide to Army Chief of Staff General Douglas MacArthur, and in 1935 Ike went with him to the Philippines when MacArthur accepted the post of chief military adviser to that nation's government.On June 25, 1942, Ike Eisenhower was chosen over 366 senior officers to lead the Armed Forces of the United States in World War II.After proving himself on the battlefields of North Africa and Italy in 1942 and 1943, Ike Eisenhower was appointed supreme commander of Operation Overlord – the Allied invasion of northwestern Europe.Ike was now commanding the Armed Forces of all 49 Allied nations – including Great Britain, the Soviet Union, and China – in the war against Hitler and his minions. He personally planned and supervised two of the most consequential military campaigns of World War II: Operation Torch in the North Africa campaign in 1942–1943 and the invasion of Normandy in 1944.Ike Eisenhower never talked like a tough guy, but only a fool would call him “weak” or “woke.”This past July, Robert Reich – an eloquent and intelligent spokesperson on the left – quoted a passage from an anti-war speech that Ike Eisenhower made at the beginning of his presidency in 1953. Reich ended his quote just prior to Ike's unsettling reference to the crucifixion of Christ.Eloquent and intelligent people on the right refused to believe that a celebrated warrior had ever made a speech that could be classified as “anti-war.”Curious, I decided to get to the bottom of it.Here is a link to the complete transcript and original recording of the speech that President Dwight D. Eisenhower made before the American Society of Newspaper Editors on April 16, 1953, from the Statler Hotel in Washington, D.C.This is the passage from that speech that got everyone worked up:“Every gun that is made, every warship launched, every rocket fired signifies, in the final sense, a theft from those who hunger and are not fed, those who are cold and are not clothed.This world in arms is not spending money alone.It is spending the sweat of its laborers, the genius of its scientists, the hopes of its children.The cost of one modern heavy bomber is this: a modern brick school in more than 30 cities.It is two electric power plants, each serving a town of 60,000 population.It is two fine, fully equipped hospitals, it is some 50 miles of concrete pavement.We pay for a single fighter plane with a half million bushels of wheat.We pay for a single destroyer with new homes that could have housed more than 8,000 people.This is, I repeat, the best way of life to be found on the road the world has been taking.This is not a way of life at all, in any true sense. Under the cloud of threatening war, it is humanity hanging from a cross of iron.”The title of that speech was originally “Chance for Peace,” but due to the vivid mental image contained in the middle of the speech, it quickly became known as the “Cross of Iron” speech.Words have impact when they contain vivid mental images.I own guns, but I am not a hunter. Neither my family nor my friends have ever seen my guns. But in the unlikely event of a home invasion, I am adequately prepared to protect

The Bonds We Make: Choosing the Right Healthcare Professional The Bonds We Make: Choosing the right healthcare professional is such a critical part of any experience. Hear from our guests, Dr. Elisa Port of the Dubin Breast Center at Mt. Sinai and The Today Show's Jill Martin about the power of a successful doctor and patient team, and the lessons they have learned in their careers, along this journey, and how they embrace life to the fullest. Jill Martin is an Emmy Award–winning television personality, New York Times Best Selling Author, entrepreneur, and the longtime Lifestyle & Commerce Correspondent on NBC's TODAY show, where she has inspired audiences for more than 20 years. She has built a successful lifestyle brand on QVC for nearly two decades, known for bringing consumers accessible elegance. Following her breast cancer diagnosis, Jill launched a new apparel line, jillmartin.com, designed to blend style with comfort while championing early health testing and advocating for women's health. Beyond television and business, Jill serves on the board of the Garden of Dreams Foundation, part of the Madison Square Garden family, dedicated to improving the lives of children facing challenges. Over the course of her career, Jill has earned twelve Emmys for her reporting, particularly with the New York Knicks. She is a graduate of the University of Michigan with a degree in communications. Her career reflects a commitment to entrepreneurship, philanthropy, and purpose-driven storytelling — blending personal experience with professional passion to empower and uplift others. Elisa Port, MD, FACS is the Chief of Breast Surgery and the Director of the Dubin Breast Center at Mount Sinai Hospital. She is also the Associate Attending Physician in the Tisch Cancer Institute at Mount-Sinai School of Medicine. After receiving her medical degree from Mount Sinai School of Medicine in 1992, Dr. Port was a general surgery resident at Cedars-Sinai Medical Center in Los Angeles. She then joined Memorial Sloan Kettering Cancer Center for a breast cancer surgery research fellowship and later completed a general surgery residency at Long Island Jewish Medical Center. She is currently working on developing research protocols for investigating the use of avatar models in triple negative breast cancer. Her clinical research work involves investigating and characterizing the role of MRI, 3D mammography, and patient decision making in breast cancer screening and surgery. Dr. Port has an active practice and performs hundreds of operations each year. She is an expert in sentinel-node biopsy, nipple sparing mastectomy, as well as the use of breast MRI in high-risk patients. She is also a member of several professional associations, including the American Society of Clinical Oncology, the American Society of Breast Diseases, the Society of Surgical Oncology, and is a Fellow of the American College of Surgeons.  Find Yonni & Heather here https://www.herhealthcompass.com/

The ASAP Career Stages Framework is a data-driven resource for executive assistants and administrative professionals to identify skills gaps and map their career progression. Want something executives and HR will listen to and that will move the needle for your career advancement? This is it. Recorded at EA Ignite Spring 2025 and produced by the American Society of Administrative Professionals - ASAP. Learn more and submit a listener question at asaporg.com/podcast.

Gastroenterology offers a unique and dynamic landscape for innovation and entrepreneurship but as providers we are often not aware of what steps we need to take. In today's episode, Dr. Parikh interviews Dr. Amitabh Chak, president of the American Society of Gastrointestinal Endoscopy. Dr. Chak shares his latest innovation trends in GI, key steps every GI entrepreneur should take, barriers we face, and how ASGE is creating the infrastructure to support this ecosystem. With this infrastructure in mind, they highlight ASGE's upcoming Festival of Innovation and EndoScopic Technology at ASGE (FIESTA) on November 14th and 15th. For those interested in learning more or registering for FIESTA, please visit www.ASGE.org/FIESTA. 

Botanical art and science truly feed off of one another. A good botanical artist must understand their subjects to do them justice which fosters a deeper understanding and appreciation for the plants, their habitats, and their role in ecosystems around the world. Join me and botanical artist Carol Woodin as we explore her love of botanical art and her role in helping the American Society of Botanical Artists connect people to plants. This episode was produced in part by Sanza, Eva, Yellowroot, Wisewren, Nadia, Heidi, Blake, Josh, Laure, R.J., Carly, Lucia, Dana, Sarah, Lauren, Strych Mind, Linda, Sylvan, Austin, Sarah, Ethan, Elle, Steve, Cassie, Chuck, Aaron, Gillian, Abi, Rich, Shad, Maddie, Owen, Linda, Alana, Sigma, Max, Richard, Maia, Rens, David, Robert, Thomas, Valerie, Joan, Mohsin Kazmi Photography, Cathy, Simon, Nick, Paul, Charis, EJ, Laura, Sung, NOK, Stephen, Heidi, Kristin, Luke, Sea, Shannon, Thomas, Will, Jamie, Waverly, Brent, Tanner, Rick, Kazys, Dorothy, Katherine, Emily, Theo, Nichole, Paul, Karen, Randi, Caelan, Tom, Don, Susan, Corbin, Keena, Robin, Peter, Whitney, Kenned, Margaret, Daniel, Karen, David, Earl, Jocelyn, Gary, Krysta, Elizabeth, Southern California Carnivorous Plant Enthusiasts, Pattypollinators, Peter, Judson, Ella, Alex, Dan, Pamela, Peter, Andrea, Nathan, Karyn, Michelle, Jillian, Chellie, Linda, Laura, Miz Holly, Christie, Carlos, Paleo Fern, Levi, Sylvia, Lanny, Ben, Lily, Craig, Sarah, Lor, Monika, Brandon, Jeremy, Suzanne, Kristina, Christine, Silas, Michael, Aristia, Felicidad, Lauren, Danielle, Allie, Jeffrey, Amanda, Tommy, Marcel, C Leigh, Karma, Shelby, Christopher, Alvin, Arek, Chellie, Dani, Paul, Dani, Tara, Elly, Colleen, Natalie, Nathan, Ario, Laura, Cari, Margaret, Mary, Connor, Nathan, Jan, Jerome, Brian, Azomonas, Ellie, University Greens, Joseph, Melody, Patricia, Matthew, Garrett, John, Ashley, Cathrine, Melvin, OrangeJulian, Porter, Jules, Griff, Joan, Megan, Marabeth, Les, Ali, Southside Plants, Keiko, Robert, Bryce, Wilma, Amanda, Helen, Mikey, Michelle, German, Joerg, Cathy, Tate, Steve, Kae, Carole, Mr. Keith Santner, Lynn, Aaron, Sara, Kenned, Brett, Jocelyn, Ethan, Sheryl, Runaway Goldfish, Ryan, Chris, Alana, Rachel, Joanna, Lori, Paul, Griff, Matthew, Bobby, Vaibhav, Steven, Joseph, Brandon, Liam, Hall, Jared, Brandon, Christina, Carly, Kazys, Stephen, Katherine, Manny, doeg, Daniel, Tim, Philip, Tim, Lisa, Brodie, Bendix, Irene, holly, Sara, and Margie.

Alice Kyteler's witchcraft trial shocked 14th century Ireland. Today, the charges against her are seen largely as nonsense, and more about personal vendettas and struggles for power. Research: Bailey, Michael D. “HISTORICAL DICTIONARY of WITCHCRAFT.” Scarecrow Press. 2003. Callan, Maeve Brigid. “The Templars, the Witch, and the Wild Irish: Vengeance and Heresy in Medieval Ireland.” Cornell University Press. 2015. “Dame Alice Kyteler.” Historic Kilkenny. https://www.historickilkenny.com/alice-kyteler Iribarren, Isabel. “Black Magic to Heresy: A Doctrinal Leap in the Pontificate of John XXII.” Church History , Mar., 2007, Vol. 76, No. 1 (Mar., 2007), pp. 32-60. Cambridge University Press on behalf of the American Society of Church History. https://www.jstor.org/stable/27644923 “Kilkenny Witch Trials.” Kilkenny Heritage Forum and Kilkenny Heritage Plan. https://kilkennyheritage.ie/2024/12/kilkenny-witch-trials/#:~:text=On%203rd%20November%201324%2C%20Petronilla,world%20for%20centuries%20to%20come. Pavlic, Brian A. “Lady Alice Kyteler Is Found Guilty of Witchcraft.” EBSCO. 2022. https://www.ebsco.com/research-starters/law/lady-alice-kyteler-found-guilty-witchcraft Ledrede, Richard. “A contemporary narrative of the proceedings against Dame Alice Kyteler, prosecuted for sorcery in 1324.” London. Printed for the Camden Society, by John Bowyer Nichols and Son. 1843. https://archive.org/details/b33096831/page/n11/mode/2up “A Medieval History.” Kyteler’s Inn. https://www.kytelersinn.com/history-of-the-inn/ Murphy, Mrs. C.J. “Alice Kyteler.” Old Kilkenny Review. 1953. https://kilkennyarchaeologicalsociety.ie/wp-content/uploads/2020/12/OKR1953-09-Claire-Murphy-Alice-Kyteler.pdf Neary, Anne. “The Origins and Character of the Kilkenny Witchcraft Case of 1324.” Proceedings of the Royal Irish Academy: Archaeology, Culture, History, Literature , 1983, Vol. 83C (1983), pp. 333-350. https://www.jstor.org/stable/25506106 Riddell, William Renwick. “First Execution for Witchcraft in Ireland.” Journal of Criminal Law and Criminology. Vol. 7, Issue 6. 1917. https://scholarlycommons.law.northwestern.edu/cgi/viewcontent.cgi?params=/context/jclc/article/1500/&path_info=83_7JAmInstCrimL_Criminology828_May1916toMarch1917_.pdf Seymour, John Drelincourt. “Dame Alice Kyteler the Sorceress of Kilkenny A.D. 1324 (Folklore History Series).” Read Books. 2011. Walsh, James. “The Popes and Science: THE HISTORY OF THE PAPAL RELATIONS TO SCIENCE DURING THE MIDDLE AGES AND DOWN TO OUR OWN TIME.” NEW YORKFORDHAM UNIVERSITY PRESS. 1915. Accessed online: https://www.gutenberg.org/files/34019/34019-h/34019-h.htm Williams, Bernadette. “The Sorcery Trial of Alice Kyteler.” History Ireland, vol. 2, no. 4, 1994, pp. 20–24. JSTOR, http://www.jstor.org/stable/27724208 See omnystudio.com/listener for privacy information.

It's time to meet the woman who set the gold standard for the role of First Lady. With her natural charm and lively spirit, Dolley Madison hosted countless gatherings for Washington's elite, turning social events into powerful political tools. Through the art of entertaining, she not only shaped the culture of the capital, but also advanced the influence and career of the nation's fourth president, James Madison. Credits: Host and Executive Producer: Sharon McMahon Supervising Producer: Melanie Buck Parks Audio Producer: Craig Thompson To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices